AG 18 | RG-50810 | EGFR Inhibitor | AmBeed-信号通路专用抑制剂

首页 / / / / AG 18

酪氨酸磷酸化抑制剂A23 /AG 18 {[allProObj[0].p_purity_real_show]}

货号：A423886 同义名： RG-50810;Tyrphostin A23

AG 18是一种表皮生长因子受体（EGFR）激酶抑制剂，IC50 为 35 μM。

AG 18 化学结构
CAS号：118409-57-7

AG 18 3D分子结构
CAS号：118409-57-7

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

购物车0 收藏询单

sales@ambeed.cn tech@ambeed.cn 400-920-2911 产品手册产品订购技术咨询
快速发货顺丰冷链运输，1-2 天到达

品质保证

技术支持

免费溶解

AG 18 纯度/质量文件产品仅供科研

货号：A423886 标准纯度： {[allProObj[0].p_purity_real_show]} 产品说明书

批次查询：批次纯度: COA SDS NMR HPLC CNMR LC-MS

全球学术期刊中引用的产品: • JMC, 2024. Ambeed. [ A919389 , A918471 , A995972 ]; • Anal. Chem., 2024, 96(50): 19947-19954. Ambeed. [ A261947 , A1165388 ]; • ACS Biomater. Sci. Eng., 2024. Ambeed. [ A220462 ]; • ACS Biomater. Sci. Eng., 2024. Ambeed. [ A165235 , A110205 ]; • Pharmaceutics, 2024, 16(12): 1546. Ambeed. [ A272538 , A187261 , A691302 , A506702 ]; 更多 >

EGFR 亚型比较

产品名称	EGFR/ErbB1 ↓ ↑	ErbB3 ↓ ↑	ErbB4 ↓ ↑	HER2/ErbB2 ↓ ↑	mutant EGFR ↓ ↑	其他靶点	纯度
WZ-3146	++++ EGFR (E746_A750), IC50: 2 nM EGFR (E746_A750/T790M), IC50: 14 nM						99%+
Daphnetin	+ EGFR, IC50: 7.67 μM					PKC,PKA	95%
Lifirafenib	++ EGFR, IC50: 29 nM				+ EGFR(T790M/L858R), IC50: 495 nM		98%
PD168393	++++ EGFR, IC50: 0.70 nM						99%+
Nazartinib	++ mutant EGFR, Ki: 0.031 μM				++ mutant EGFR, Ki: 0.031 μM		98%
Norcantharidin	✔						98%
CL-387785	++++ EGFR, IC50: 370 pM						98%
WHI-P154	+++ EGFR, IC50: 4 nM					VEGFR,Src	98%
Tyrphostin A9	+ EGFR, IC50: 460 μM					PDGFR	98%
AG 555	+ EGFR, IC50: 0.7 μM						98%
AG 494	+ EGFR, IC50: 1.2 μM						99%+
AG-556	+ EGFR, IC50: 5 μM						98%
RG13022	+ EGFR, IC50: 4 μM						99%+
Tyrphostin RG 14620	✔						99%+
Vandetanib	+ EGFR, IC50: 500 nM						99%
CNX-2006	++ mutant EGFR, IC50: <20 nM				++ mutant EGFR, IC50: <20 nM		99%
AZD3759	++++ EGFR (L858R), IC50: 0.2 nM EGFR (WT), IC50: 0.3 nM						98%
Erlotinib	++++ EGFR, IC50: 2 nM						95%
Saracatinib	+++ EGFR (L861Q), IC50: 4 nM EGFR, IC50: 5 nM						99%+
AG1557	✔						99%
Rociletinib	++ EGFR (L858R/T790M), Ki: 21.5 nM EGFR (wt), Ki: 303.3 nM						98%
AG490	+ EGFR, IC50: 0.1 μM						98%
Cetuximab	++++ EGFR, Kd: 0.39 nM						99%
Osimertinib	++ WT EGFR, IC50: 12.92 nM L858R/T790M EGFR, IC50: 11.44 nM						98%
Osimertinib mesylate	✔						98% (Content MsOH 15.2-18.2%)
Chrysophanol	✔					mTOR	98%
PD153035	++++ EGFR, Ki: 5.2 pM						99%+
Olmutinib	✔					BTK	99%+
WZ4002	++++ EGFR (L858R), IC50: 2 nM EGFR (L858R/T790M), IC50: 8 nM						99%+
Icotinib	+++ EGFR, IC50: 5 nM						99%
Desmethyl Erlotinib HCl	++++ EGFR, IC50: 2 nM						99%
Cyasterone	✔						99%+
PP 3	+ EGFR tyrosine kinase, IC50: 2.7 μM						98%
WZ8040	✔						99%+
(-)-Epigallocatechin Gallate	✔						99%
AG 18	+ EGFR, IC50: 35 μM						99%+
O-Desmethyl gefitinib	++ EGFR, IC50: 36 nM						99%
Falnidamol	✔						99%+
AZ-5104	++++ EGFR (L858R), IC50: 6 nM EGFR (L861Q) , IC50: <1 nM		+++ ErbB4, IC50: 7 nM			BRK	99%+
Butein	✔						95%
Genistein	✔						98%
SU5214	+ EGFR, IC50: 36.7 μM						99%+
Naquotinib	✔						99%+
Gefitinib	++ EGFR, IC50: 15.5 nM				+ EGFR (858R/T790M), IC50: 823.3 nM		98%
Theliatinib	+++ WT EGFR, IC50: 3 nM				++ EGFR T790M/L858R, IC50: 22 nM		99%
Lazertinib	++++ WT EGFR, IC50: 76 nM L858R/T790M EGFR, IC50: 2 nM				++++ Del19/T790M, IC50: 1.7 nM		99%+
Gefitinib-based PROTAC 3	++ EGFR, DC50: 22.3 nM						99%+
MTX-211	✔					PI3K	98%
(E)-AG 99	✔						99%+
Licochalcone D	✔					PARP,Caspase	99%
Zipalertinib	+++ EGFR WT, IC50: 8 nM EGFR (L861Q), IC50: 4.1 nM		+++ HER4, IC50: 4 nM		++++ EGFR L858R, IC50: 2 nM EGFR(d746-750), IC50: 1.4 nM		97%
JND3229	+++ EGFR WT, IC50: 6.8 nM				++ EGFR L858R/T790M, IC50: 30.5 nM		99%+
Firmonertinib mesylate	✔						99%+
Tyrphostin AG30	✔						99%+
EGFR-IN-12	++ EGFR, IC50: 21 nM						99%+
Mobocertinib	✔						98%
(Rac)-JBJ-04-125-02	✔						99%
(S)-Sunvozertinib	✔						99%
BLU-945	✔						95%
Poziotinib	+++ HER1, IC50: 3.2 nM		++ HER4, IC50: 23.5 nM	+++ HER2, IC50: 5.3 nM			98%
TAK-285	++ EGFR/HER1, IC50: 23 nM		+ HER4, IC50: 260 nM	++ HER2, IC50: 17 nM			99%+
ARRY-380 analog				✔			99%
Canertinib	++++ EGFR, IC50: 1.5 nM			+++ ErbB2, IC50: 9.0 nM			99%+
Dacomitinib	+++ EGFR, IC50: 6.0 nM		+ ErbB4, IC50: 73.7 nM	+ ErbB2, IC50: 45.7 nM			98%
EGFR/ErbB-2/ErbB-4 inhibitor-2			+ ErbB4, IC50: 1.91 μM	+ ErbB2, IC50: 0.08 μM			99%+
(E/Z)-CP-724714				++ HER2/ErbB2, IC50: 10 nM			98+%
Lapatinib	++ EGFR, IC50: 10.8 nM		+ ErbB4, IC50: 367 nM	+++ ErbB2, IC50: 9.2 nM			98%
AEE788	++++ EGFR, IC50: 2 nM		+ HER4/ErbB4, IC50: 160 nM	+++ HER2/ErbB2, IC50: 6 nM		c-Fms	98+%
AV-412 free base	++++ EGFR, IC50: 0.75 nM			++ ErbB2, IC50: 19 nM	++++ EGFR^T790M, IC50: 0.79 nM EGFR^L858R/T790M, IC50: 0.51 nM		98+%
Neratinib	+ EGFR, IC50: 92 nM			+ HER2, IC50: 59 nM		Src	98%
BMS-599626	++ HER1, IC50: 20 nM		+ HER4, IC50: 190 nM	++ HER2, IC50: 30 nM			99+%
Tucatinib				+++ ErbB2, IC50: 8 nM			98%
Allitinib	++++ EGFR, IC50: 0.5 nM		++++ ErbB4, IC50: 0.8 nM	+++ ErbB2, IC50: 3.0 nM			99%
Pelitinib	+ EGFR, IC50: 38.5 nM			+ ErbB2, IC50: 1.255 μM		Src,Raf	99%+
Sapitinib	+++ EGFR, IC50: 4 nM	+++ ErbB3, IC50: 4 nM		+++ ErbB2, IC50: 3 nM			99%+
CUDC-101	+++ EGFR, IC50: 2.4 nM			++ HER2, IC50: 15.7 nM		HDAC	99%+
Varlitinib	+++ ErbB1, IC50: 7 nM			++++ ErbB2, IC50: 2 nM			99%+
Afatinib dimaleate	++++ EGFR (wt), IC50: 0.5 nM EGFR (L858R/T790M), IC50: 0.4 nM			++ HER2, IC50: 14 nM			98%
Canertinib dihydrochloride	+++ EGFR, IC50: 7.4 nM			+++ ErbB2, IC50: 9 nM			99%
Allitinib tosylate	++++ EGFR (T790M/L858R), IC50: 12 nM EGFR, IC50: 0.5 nM		++++ ErbB4, IC50: 0.8 nM	+++ ErbB2, IC50: 3.0 nM			99%
Tyrphostin AG 528	+ EGFR, IC50: 4.9 μM			+ HER2, IC50: 2.1 μM			97%
Afatinib	++++ EGFR (L858R), IC50: 10 nM EGFR (wt), IC50: 0.5 nM		++++ ErbB4, IC50: 1 nM	++ HER2, IC50: 14 nM			99%
Pyrotinib dimaleate	++ EGFR, IC50: 0.013 μM			++ HER2, IC50: 0.038 μM			98%
Epertinib HCl	++++ EGFR, IC50: 1.48 nM		+++ HER4, IC50: 2.49 nM	+++ HER2, IC50: 7.15 nM			99%
Tuxobertinib	++++ EGFR, Kd: 0.2 nM			++++ HER2, Kd: 0.76 nM			99%
ALK-IN-1					++ EGFR(C797S/del19), IC50: 138.6 nM EGFR(del19), IC50: 36.8 nM	ALK	99%
Brigatinib					+ EGFR(C797S/T790M/del19), IC50: 67.2 nM EGFR(del19), IC50: 39.9 nM	ALK,FLT3	98%
Avitinib					++++ EGFR L858R/T790M, IC50: 0.18 nM	BTK	99%+
EAI045					✔		97%
Almonertinib					✔		99%
BI-4020					++++ EGFR^{del19 T790M C797S}, IC50: 0.2 nM		99%+
EGFR-IN-7					++++ EGFR^{d746-750/T790M/C797S}, IC50: 0.26 nM EGFR^L858R/T790M, IC50: 0.19 nM		99%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

AG 18 生物活性

靶点

EGFR/ErbB1

EGFR, IC50:35 μM

描述

Tyrphostin 23 (AG 18) is an EGFR inhibitor with an IC50 and Kiof 35 and 11 μM, respectively^[3]. Tyrphostins (structural analogs of tyrosine) are inhibitors of tyrosine kinases and function by binding to the active sites of the enzymes. Control tyrphostins, active as inhibitors of tyrosine kinase activity, but incapable of inhibiting the YXXPhi motif/mu2 interaction, did not inhibit endocytosis^[4]. The stimulation of glycolytic flux by T23 (Tyrphostin 23) was reversible, completely abolished upon removal of the compound and not found in presence of other known inhibitors of endocytosis. T23-sensitive phosphorylation/dephosphorylation events are involved in the regulation of astrocytic glycolysis^[5]. Tyrphostin A23 and A63 stimulate the cAMP-activated CFTR (cystic fibrosis transmembrane conductance regulator) Cl(-) channel via a PTK(an inhibitor of protein tyrosine kinase)-independent, structure-dependent mechanism^[6].

AG 18 临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT01306305	Influenza	Phase 4	Completed	-	Switzerland ... 展开 >> Covance Clinical Research Unit AG Allschwil, Switzerland, 4123 收起 <<
NCT02322437	Mental Disorders	Not Applicable	Completed	-	Switzerland ... 展开 >> Psychiatric Services Aargau AG Brugg, Aargau, Switzerland, 5201 收起 <<
NCT01306305	-		Completed	-	-

AG 18 参考文献

[1]Nanzer AM, Khalaf S, et al. Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway. Eur J Endocrinol. 2004 Aug;151(2):233-40.

[2]Gazit A, Yaish P, et al. Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J Med Chem. 1989 Oct;32(10):2344-52.

[3]Gazit A, Yaish P, Gilon C, Levitzki A. Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J Med Chem. 1989 Oct;32(10):2344-52

[4]Banbury DN, Oakley JD, Sessions RB, Banting G. Tyrphostin A23 inhibits internalization of the transferrin receptor by perturbing the interaction between tyrosine motifs and the medium chain subunit of the AP-2 adaptor complex. J Biol Chem. 2003 Apr 4;278(14):12022-8

[5]Blumrich EM, Kadam R, Dringen R. The Protein Tyrosine Kinase Inhibitor Tyrphostin 23 Strongly Accelerates Glycolytic Lactate Production in Cultured Primary Astrocytes. Neurochem Res. 2016 Oct;41(10):2607-2618

[6]Niisato N, Nishio K, Marunaka Y. Activation of CFTR Cl(-) channel by tyrphostins via a protein tyrosine kinase-independent pathway in forskolin-stimulated renal epithelial A6 cells. Life Sci. 2002 Jul 26;71(10):1199-207

AG 18 实验方案

计算器

存储液制备

1mg

5mg

10mg

1 mM

5 mM

10 mM

5.37mL

1.07mL

0.54mL

26.86mL

5.37mL

2.69mL

53.72mL

10.74mL

5.37mL

AG 18 技术信息

CAS号	118409-57-7
分子式	C₁₀H₆N₂O₂
分子量	186.167

别名	RG-50810;Tyrphostin A23;Tyrphostin AG-18;RG-50858;TX 825;Tyrphostin 23
运输	蓝冰

存储条件

In solvent -20°C:3-6个月-80°C:12个月

Pure form Sealed in dry,Store in freezer, under -20°C

溶解度

DMSO: 105 mg/mL(564.01 mM)，配合低频超声助溶，注意：DMSO长时间开封后，会吸水并导致溶解能力下降，请避免使用长期开封的DMSO

动物实验配方

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT01306305	Influenza	Phase 4	Completed	-	Switzerland ... 展开 >> Covance Clinical Research Unit AG Allschwil, Switzerland, 4123 收起 <<
NCT02322437	Mental Disorders	Not Applicable	Completed	-	Switzerland ... 展开 >> Psychiatric Services Aargau AG Brugg, Aargau, Switzerland, 5201 收起 <<
NCT01306305	-		Completed	-	-
NCT01303510	Influenza	Phase 4	Completed	-	Switzerland ... 展开 >> Covance Clinical Research Unit AG Allschwil, Switzerland, 4123 收起 <<
NCT01303510	-		Completed	-	-
NCT02238756	Rabies	Phase 1	Completed	-	Germany ... 展开 >> CRS Clinical Research Services Mönchengladbach GmbH Mönchengladbach, Germany 收起 <<
NCT01117181	-		Completed	-	-
NCT01126099	Alzheimer's Disease	Not Applicable	Completed	-	United States, Washington ... 展开 >> Veterans Affairs Puget Sound Health Care System Seattle, Washington, United States, 98108 收起 <<
NCT01117181	Apathy Alzhei... 展开 >>mer's Disease 收起 <<	Phase 2	Completed	-	United States, Maryland ... 展开 >> Johns Hopkins University Baltimore, Maryland, United States, 21224 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29406 Canada, Ontario Sunnybrook Health Sciences Centre Toronto, Ontario, Canada 收起 <<
NCT01126099	-		Completed	-	-
NCT03512730	Peri-Implantitis	Phase 2	Completed	-	-
NCT03564821	IDH1 Mutation Myeloid Neoplasm... 展开 >>s 收起 <<	Phase 1	Not yet recruiting	July 31, 2024	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Not yet recruiting Boston, Massachusetts, United States, 02214 Contact: Amir T Fathi, MD 617-724-4000 afathi@partners.org Principal Investigator: Amir T Fathi, MD 收起 <<
NCT01251887	Weight Gain H... 展开 >>ealthy Subjects Obesity Women 收起 <<	Not Applicable	Completed	-	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT03115840	-		Recruiting	July 1, 2021	United States, Tennessee ... 展开 >> Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37212 Contact: Nathan E Brummel, MD, MSCI 615-343-3957 nathan.brummel@vanderbilt.edu 收起 <<
NCT02889224	Cushing's Syndrome	Not Applicable	Completed	-	France ... 展开 >> Service d'Endocrinologie, Hopital Haut-Leveque Pessac, France, 33600 收起 <<
NCT00455741	Postmenopause ... 展开 >> Aging 收起 <<	Phase 1 Phase 2	Completed	-	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 <<
NCT00455741	-		Completed	-	-
NCT00952744	-		Completed	-	United States, California ... 展开 >> Stanford University Hospital Palo Alto, California, United States, 94304 University of California, San Diego San Diego, California, United States, 92103 University of California, San Francisco San Francisco, California, United States, 94110 United States, Kansas Kansas University Medical Center Kansas City, Kansas, United States, 66160 United States, Maryland University of Maryland Baltimore, Maryland, United States, 21201-1595 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Henry Ford Hospital Detroit, Michigan, United States, 48202-2689 United States, Minnesota Hennepin County Medical Center Minneapolis, Minnesota, United States, 55404 United States, Ohio The Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298-0401 收起 <<
NCT00900770	-		Unknown	March 2014	United States, Massachusetts ... 展开 >> Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Kelly O'Keefe 617-726-6212 kokeefe1@partners.org Contact: Meghan Frey 617-732-8085 mfrey1@partners.org Principal Investigator: Reisa A. Sperling, MD Sub-Investigator: Keith A. Johnson, MD 收起 <<
NCT00979043	Knee Osteoarthritis	Not Applicable	Completed	-	United States, North Carolina ... 展开 >> Wake Forest University Winston-Salem, North Carolina, United States, 27157 收起 <<
NCT03723850	Effect of tDCS on Memory in Ol... 展开 >>der and Younger Adults 收起 <<	Not Applicable	Not yet recruiting	December 2020	-
NCT00108069	-		Completed	-	-
NCT00667394	Glioblastoma ... 展开 >>Gliosarcoma Anaplastic Astrocytoma Anaplastic Oligodendroglioma Anaplastic Mixed Oligoastrocytoma 收起 <<	Phase 2	Completed	-	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT03598010	Diarrhea Acut... 展开 >>e Gastroenteritis Acute Diarrhea 收起 <<	Phase 4	Not yet recruiting	March 2020	-
NCT00185367	Contraception	Phase 3	Completed	-	Czech Republic ... 展开 >> Soukroma gynekologicka ambulance Fulnek, Czech Republic, 74245 Soukroma gynekologicka ambulance Ostrava - Zabreh, Czech Republic, 70400 Soukroma gynekologicka ambulance Plzen, Czech Republic, 30708 Provozorna Gynekologicka ordinace Dr. Tesar Praha 10, Czech Republic, 109 00 Femina Sana s.r.o Praha, Czech Republic, 13000 France Dr. Jocelyne Nataf-Maurin Brignoles, France, 83170 Dr. Marie-Helene Malbranche-Aupecle Dijon, France, 21000 Centre Hospitalier de l Estuaire Honfleur, France, 14601 Dr. Annette Mercier Morlaix, France, 29600 Clinique d Occitanie Muret, France, 31600 Centre Medical du Val de Loire Nevers, France, 58000 Dr. Anne-Isabelle Richet Paris, France, 75007 Cabinet medical Quetigny, France, 21800 Dr. Gwendoline Servan Tarare, France, 69170 Dr. Aliette Siboni-Frisch Toulouse, France, 31000 Germany Frauenarztpraxis Dr. Buchberger Neubiberg, Bayern, Germany, 85579 Praxis Hr. Dr. R. Kuett Nürnberg, Bayern, Germany, 90491 Praxis Dr. Larbig Fulda, Hessen, Germany, 36037 Praxis Fr. Dr. J. Schmidt-Pich Hannover, Niedersachsen, Germany, 30159 Frauenarztpraxis Dr. Wetzel Blankenburg, Sachsen-Anhalt, Germany, 38889 Frauenarztpraxis Dipl. med. Michael Stellmacher Burg, Sachsen-Anhalt, Germany, 39288 Praxis Fr. Dr. A. Braune Magdeburg, Sachsen-Anhalt, Germany, 39104 Praxis Hr. Prof. Dr. H.-J. Ahrendt Magdeburg, Sachsen-Anhalt, Germany, 39126 Praxis Fr. Dr. K. Kopprasch Dresden, Sachsen, Germany, 01169 Praxis Fr. R. Hellmich Dresden, Sachsen, Germany, 01187 Praxis Fr. Dr. A. Münzberger Döbeln, Sachsen, Germany, 04720 Frauenarztpraxis Dr. Bernd Pittner Leipzig, Sachsen, Germany, 04207 Praxis Fr. Dr. C. Burgkhardt Leipzig, Sachsen, Germany, 04299 Praxis Hr. R. Wähnert Gera, Thüringen, Germany, 07545 Praxis Fr. Dr. A.Mönch-Hering Kahla, Thüringen, Germany, 07768 Frauenarztpraxis Hr. Dr. H. Lindecke Berlin, Germany, 10247 Praxis Fr. Dr. B. Heuberger Berlin, Germany, 12587 Praxis Hr. Dr. Karl-Heinz Belling Berlin, Germany, 13086 Frauenarztpraxis Hr. Dr. B. Hamann Berlin, Germany, 13187 收起 <<
NCT00667394	-		Completed	-	-
NCT00498784	Contraception	Phase 4	Completed	-	France ... 展开 >> Bordeaux, Gironde, France, 33076 收起 <<
NCT02255058	-		Completed	-	Argentina ... 展开 >> REMEO El Pilar Buenos Aires, Argentina Colombia REMEO Bogota Bogota, Colombia REMEO Medellin Medellin, Colombia Germany REMEO Centre Berlin, Germany REMEO Mahlow Berlin, Germany 收起 <<
NCT03322696	-		Recruiting	September 30, 2019	Italy ... 展开 >> Raimondo De Cristofaro Recruiting Roma, Italy, 00168 Contact: Maurizio Pompili, Ass. prof. 0630151 maurizio.pompili@unicatt.it 收起 <<
NCT00453362	-		Completed	-	-
NCT00108069	Glioma	Phase 2	Completed	-	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT01485354	Stroke	Not Applicable	Terminated(Lack of funding)	-	United States, Massachusetts ... 展开 >> Spaulding Rehabilitation Hospital Boston Boston, Massachusetts, United States, 02129 收起 <<
NCT02433522	ANCA-associated Vasculitides	Phase 3	Active, not recruiting	September 2018	France ... 展开 >> Hopital cochin Paris, France, 75014 收起 <<
NCT00413595	-		Recruiting	June 2019	Austria ... 展开 >> Universitätsklinikum für Neurologie Recruiting Graz, Austria, A-8036 Contact: Franz Fazekas, Prof., MD +43-316-385- ext -2981 franz.fazekas@meduni-graz.at Contact: Gabriele Schrotter, MD +43-316-385- ext -80424 gabriele.schrotter@meduni-graz.at Principal Investigator: Franz Fazekas, Prof., MD Sub-Investigator: Gabriele Schrotter, MD Sub-Investigator: Barbara Ebenbauer, MD Croatia Department of Neurology, University Hospital Sestre Milosrdnice Recruiting Zagreb, Croatia, 10000 Contact: Vida Demarin, Prof. MD +385-13-787- ext -740 vida.demarin@zg.t-com.hr Contact: Marijana Bosnar-Puretic, MD +385-91-554- ext -740 mbos-puretic@inet.hr Principal Investigator: Vida Demarin, Prof. MD Sub-Investigator: Marijana Bosnar-Puretic, MD France Hopital Neurologique de Lyon, Service d'urgences Neurovasculaires Recruiting Lyon, France, F-69003 Contact: Laurent Derex, MD +33-472-357- ext -809 laurent.derex@chu-lyon.fr Principal Investigator: Laurent Derex, MD Georgia Department of Neurology, S. Khechinashvili University clinic of Tbilisi state medical university Recruiting Tbilisi, Georgia, 0179 Contact: Marina Janelidze, Prof. MD +995-322-268- ext -04 marjaneli@yahoo.com Contact: Maia Beridze, Prof. MD +995-322-268- ext -04 postdoc2002@yahoo.com Principal Investigator: Marina Janelidze, Prof. MD Sub-Investigator: Maia Beridze, Prof. MD Germany Department of Neurology, Klinikum Hohe Warte Recruiting Bayreuth, Germany, 95445 Contact: Patrick Oschmann, Prof., MD +49-921-400- ext -4602 neurologie@klinikum-bayreuth.de Contact: Michael Pott, MD +49-921-400- ext -4602 neurologie@klinikum-bayreuth.de Principal Investigator: Patrick Oschmann, Prof., MD Sub-Investigator: Michael Pott, MD Charite Campus Benjamin Franklin, Dept. of Neurology Recruiting Berlin, Germany, D-12200 Contact: Gerhard J. Jungehülsing, MD +49-30-8445-64- ext -4088 jan.jungehuelsing@charite.de Contact: Wolf Schmidt, MD +49-30-8445- ext -4101 wolf.schmidt@charite.de Principal Investigator: Gerhard J. Jungehülsing, MD Sub-Investigator: Wolf Schmidt, MD Department of Neurology, Allgemeines Krankenhaus Celle Recruiting Celle, Germany, 29223 Contact: Wolfgang Heide, Prof. MD +49-5141-72- ext -1400 wolfgang.heide@ak-h-celle.de Contact: Oliver Pape, MD +49-5141-72- ext -6489 oliver.pape@akh-celle.de Principal Investigator: Wolfgang Heide, Prof. MD Sub-Investigator: Oliver Pape, MD Department of Neurology, Klinikum Chemnitz gGmbH Recruiting Chemnitz, Germany, 09131 Contact: Juergen Klingelhoefer, Prof. MD +49-371-333- ext -10530 neurologie@skc.de Contact: Sebastian Schwarz, MD 49-371-333- ext -12344 neurologie@skc.de Principal Investigator: Juergen Klingelhoefer, Prof. MD Sub-Investigator: Sebastian Schwarz, MD Department of Neurology, Universitaetsklinikum Carl Gustav Carus Recruiting Dresden, Germany, 01307 Contact: Heinz Reichmann, Prof. MD +49-351-458- ext -3565 heinz.reichmann@uniklinikum-dresden.de Principal Investigator: Heinz Reichmann, Prof. MD Sub-Investigator: Hjördis Hentschel, MD Heinrich-Heine-University Duesseldorf, Dept. of Neurology Recruiting Duesseldorf, Germany, D-40225 Contact: Sebastian Jander, Prof., MD +49-211-811- ext -8978 jander@uni-duesseldorf.de Contact: Christina Boettcher +49-211-811- ext -18465 christina.boettcher@uni-duesseldorf.de Principal Investigator: Sebastian Jander, Prof., MD Sub-Investigator: Christina Boettcher University of Giessen-Marburg Dept. of Neurology Recruiting Giessen, Germany, D-35385 Contact: Manfred Kaps, Prof., MD +49-641-994- ext -5300 manfred.kaps@neuro.med.uni-giessen.de Contact: Christian Tanislav, MD +49-641-994- ext -5316 christian.tanislav@uniklinikum-giessen.de Principal Investigator: Manfred Kaps, Prof., MD Sub-Investigator: Christian Tanislav, MD Sub-Investigator: Jens Allendoerfer, MD Department of Neurology, Universitaetsklinikum Hamburg-Eppendorf Recruiting Hamburg, Germany, 20246 Contact: Michael Rosenkranz, MD +49-40-42803- ext -4730 rosenkranz@uke-uni-hamburg.de Contact: Anna C Krützelmann, MD +49-40-42803- ext -9824 a.kruetzelmann@uke-uni-hamburg.de Principal Investigator: Michael Rosenkranz, MD Sub-Investigator: Anna C. Krützelmann, MD Department of Neurology, Universitaetsklinikum Jena Recruiting Jena, Germany, 07740 Contact: Otto W. Witte, Prof. MD +49-3641-932- ext -3401 otto.witte@med.uni-jena.de Contact: Dirk Brämer, MD +49-3641-935- ext -266 dirk.braemer@med.uni-jena.de Principal Investigator: Otto Witte, Prof. MD Sub-Investigator: Dirk Brämer, MD Sub-Investigator: Albrecht Günther, MD Department of Neurology, Universitaetsklinikum Leipzig Recruiting Leipzig, Germany, 04103 Contact: Dietmar Schneider, Prof. MD +49-341-9724- ext -221 dietmar.schneider@medizin.uni-leipzig.de Contact: Dominik Michalski, MD +49-341-9724- ext -206 dominik.michalski@medizin.uni-leipzig.de Principal Investigator: Dietmar Schneider, Prof. MD Sub-Investigator: Dominik Michalski, MD Sub-Investigator: Wolfgang Kloppig, MD Dept. of Neurology, Ökumenisches Hainich Klinikum gGmbH Recruiting Mühlhausen, Germany, 99974 Contact: Marek Jauß, PD MD +49-3601-803- ext -456 m.jauss@oehk.de Principal Investigator: Marek Jauß, PD MD Sub-Investigator: Felicita Sojka, MD Sub-Investigator: Lars Adam, MD Ludwig-Maximilians-University of Munich, Klinikum München-Großhadern, Dept. of Neurology Recruiting München, Germany, D-81377 Contact: Martin Dichgans, Prof., MD +49-89-7095- ext -6670 martin.dichgans@med.uni-muenchen.de Contact: Anna Karpinska, MD +49-89-7095- ext -6672 anna.karpinska@med.uni-muenchen.de Principal Investigator: Martin Dichgans, Prof., MD Sub-Investigator: Anna Karpinska, MD Department of Neurology, University Tuebingen Recruiting Tuebingen, Germany, 72076 Contact: Arthur Melms, Prof. MD +49-7071-29- ext -82057 arthur.melms@uni-tuebingen.de Contact: Karl Horber +49-7071-29- ext -82051 karl.horber@uni-tuebingen.de Principal Investigator: Arthur Melms, Prof., MD Sub-Investigator: Karl Horber University of Ulm, Department of Neurology Recruiting Ulm, Germany, D-89081 Contact: Albert Ludolph, Prof., MD +49-731-177- ext -1201 albert.ludolph@uni-ulm.de Contact: Roman Huber, MD +49-731-177- ext -5222 r.huber@uni-ulm.de Principal Investigator: Albert Ludolph, Prof., MD Sub-Investigator: Roman Huber, MD Poland Institute of Psychiatry and Neurology, Dept. of Neurology Recruiting Warsaw, Poland, 02-957 Contact: Anna Czlonkowska, Prof. MD +48-22-842- ext -7683 czlonkow@ipin.edu.pl Contact: Beata Hyzorek-Bazejewska, MD +48-22-842- ext -7683 hyzorek@ipin.edu.pl Principal Investigator: Anna Czlonkowska, Prof. MD Sub-Investigator: Beata Hyzorek-Bazejewska, MD Sub-Investigator: Anna Baranowska, MD Portugal Centro Hospitalar de Lisboa Central, Servico de Neurologia Recruiting Lisboa, Portugal, 1150-199 Contact: Alexandre Amaral e Silva, MD +351-21-8841- ext -303 zefiros@netcabo.pt Contact: Joacquim Machado Candido, MD +351-21-8841- ext -855 secunid.ucv@chlisboa-zc.min-saude.pt Sub-Investigator: Alexandre Amaral e Silva, MD Principal Investigator: Joacquim Machado Candido, MD 收起 <<
NCT00950430	Alzheimer's Disease ... 展开 >> Dementia With Lewy Bodies Frontotemporal Dementia Vascular Dementia 收起 <<	Phase 4	Enrolling by invitation	April 2023	United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 <<
NCT00453362	Non-Small Cell Lung Cancer	Phase 1 Phase 2	Completed	-	-
NCT00242593	Mild Cognitive Impairment	Phase 2	Unknown	December 2011	United States, Arizona ... 展开 >> Banner Alzheimer Institute Phoenix, Arizona, United States, 85006 United States, California UCLA Alzheimer's Disease Center Los Angeles, California, United States, 90095 United States, Washington University of Washington/VA Puget Sound Health Care System Seattle/Tacoma, Washington, United States, 98108 收起 <<
NCT00163306	Gastroesophageal Reflux	Phase 3	Completed	-	-
NCT00901524	Hepatitis	Phase 2	Completed	-	France ... 展开 >> Hôpital Tenon Service des Maladies Infectieuses Paris, France, 75970 收起 <<
NCT02316457	Breast Cancer (Triple Negative... 展开 >> Breast Cancer (TNBC)) 收起 <<	Phase 1	Recruiting	April 2020	Belgium ... 展开 >> UZ Brussels - Department medical and molecular oncology Withdrawn Brussels, Belgium, 1090 Germany Johannes Gutenberg University Recruiting Mainz, RLP, Germany, 55131 National Center for Tumor Diseases (NCT) Recruiting Heidelberg, Germany, 69120 Dr. Horst Schmidt-Kliniken Wiesbaden Not yet recruiting Wiesbaden, Germany, 65199 Sweden Uppsala University Hospital Recruiting Uppsala, Sweden, 75185 收起 <<
NCT01485354	-		Terminated(Lack of funding)	-	-
NCT00859118	Neoplasms	Phase 1	Completed	-	United States, Wisconsin ... 展开 >> University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53575 收起 <<
NCT03755557	Allergic Rhinitis ... 展开 >> Allergic Conjunctivitis Hayfever 收起 <<	Phase 3	Enrolling by invitation	April 30, 2019	Austria ... 展开 >> Vienna Challenge Chamber Vienna, Austria, 1140 收起 <<
NCT01631110	-		Completed	-	-
NCT02667496	Dementia Alzheimer's Type	Phase 2	Withdrawn(Slow recruitment)	-	United States, Texas ... 展开 >> Investigational Site Number 840001 Houston, Texas, United States, 77030 收起 <<
NCT02151916	Dental Caries ... 展开 >> Early Childhood Caries 收起 <<	Phase 3	Unknown	July 2016	Canada, Ontario ... 展开 >> University of Toronto Faculty of Dentistry Toronto, Ontario, Canada, M5G 1G6 收起 <<
NCT01631110	Influenza	Phase 3	Completed	-	Switzerland ... 展开 >> Covance Clinical Research Unit AG Allschwil, Switzerland, 4123 收起 <<
NCT02289794	E.Coli Infections	Phase 1	Completed	-	Switzerland ... 展开 >> Hôpitaux Universitaires de Genève Geneve, GE, Switzerland, 1211 收起 <<
NCT02257385	-		Completed	-	-
NCT01004328	Adverse Outcomes	Not Applicable	Completed	-	United States, Massachusetts ... 展开 >> Fallon Clinic Worcester, Massachusetts, United States, 01605 收起 <<
NCT01018641	Bacterial Infections ... 展开 >> Staphylococcal Vaccines Immunotherapy, Active Staphylococcal Skin Infections Staphylococcal Infections 收起 <<	Phase 1	Completed	-	Australia, Queensland ... 展开 >> Pfizer Investigational Site Herston, Queensland, Australia, 4029 Australia, South Australia Pfizer Investigational Site Adelaide, South Australia, Australia, 5000 Pfizer Investigational Site North Adelaide, South Australia, Australia, 5006 Australia, Victoria Pfizer Investigational Site Prahran, Victoria, Australia, 3004 Australia, Western Australia Pfizer Investigational Site Subiaco, Western Australia, Australia, 6008 收起 <<
NCT01968213	-		Active, not recruiting	-	-
NCT00177385	Sleep Health ... 展开 >>Promotion 收起 <<	Not Applicable	Completed	-	-
NCT01968213	Ovarian Cancer ... 展开 >> Fallopian Tube Cancer Peritoneal Cancer 收起 <<	Phase 3	Active, not recruiting	June 2020	-
NCT03282916	Alzheimer Disease ... 展开 >> Herpes Simplex 1 Herpes Simplex 2 收起 <<	Phase 2	Recruiting	August 2022	United States, New York ... 展开 >> New York State Psychiatric Institute Recruiting New York, New York, United States, 10032 Contact: Julianna Pollina, BS 646-774-8638 julianna.pollina@nyspi.columbia.edu Contact: Mariasofia Katsikoumbas, BS 646-774-8641 mariasofia.katsikoumbas@nyspi.columbia.edu Principal Investigator: Davangere Devanand, MD Sub-Investigator: Edward Huey, MD Sub-Investigator: Yaakov Stern, PhD 收起 <<
NCT02689726	HPV 16- and/or HPV 18-Infected... 展开 >> Women With Normal Cytology, ASCUS, or LSIL 收起 <<	Phase 1	Terminated(Lack of efficacy in... 展开 >> European Phase 2 study) 收起 <<	-	United States, Kentucky ... 展开 >> University of Louisville Louisville, Kentucky, United States, 40208 United States, North Carolina Wake Research Associates, LLC Raleigh, North Carolina, United States, 27612 United States, Ohio Clinical Research Advantage, Inc./ Columbus Obstetricians and Gynecology, Inc. Columbus, Ohio, United States, 43213 United States, Pennsylvania Planned Parenthood Southeastern Pennsylvania Philadelphia, Pennsylvania, United States, 19107 收起 <<
NCT02392689	Heart Failure ... 展开 >> Infection 收起 <<	Not Applicable	Terminated(At 75% patient comp... 展开 >>letion overall mortality was much lower than expected and without significant difference at day 90. No chance to reach the primary endpoint.) 收起 <<	-	Denmark ... 展开 >> Aalborg Sygehus Aalborg, Denmark, 9000 Herlev Hospital Herlev, Denmark, 2730 Odense University Hospital Odense, Denmark, 5000 Germany Kerckhoff-Klinik Bad Nauheim, Germany, 61231 Charite Universitätsmedizin Berlin - CCM Berlin, Germany, 10117 Charite Universitätmedizin Berlin - CVK Berlin, Germany, 13353 Universitätsklinikum Frankfurt Frankfurt am Main, Germany, 60596 Klinikum Frankfurt Höchst GmbH Frankfurt am Main, Germany, 65929 Universitätsmedizin Göttingen Göttingen, Germany, 37075 Medizinische Universitätsklinik Heidelberg - Medizinische Klinik III Heidelberg, Germany, 69120 Universitäres Herzzentrum Lübeck Lubeck, Germany, 23538 Klinikum Nürnberg Nord Nürnberg, Germany, 90419 Netherlands University Medical Center Groningen Groningen, Netherlands, 9713 Maastricht UMC+ Maastricht, Netherlands, 6229 Spain Hospital Clinico San Carlos Madrid, Spain, 28040 收起 <<
NCT03709329	Chronic Post-stroke Hemiplegic... 展开 >> Patients 收起 <<	Not Applicable	Recruiting	October 15, 2019	Korea, Republic of ... 展开 >> Department of Rehabilitation Medicine, Severance Hospital, Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine Recruiting Seoul, Korea, Republic of, 03722 Contact: Deog-Young Kim, MD, Ph.D 82-2-2228-3714 kimdy@yuhs.ac 收起 <<
NCT03373604	Alzheimer Disease	Phase 2	Enrolling by invitation	August 20, 2021	United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 <<
NCT03691077	Multiple Sclerosis ... 展开 >> Relapse Primary Progressive Multiple Sclerosis 收起 <<	Phase 3	Recruiting	September 2022	France ... 展开 >> Hôpital Saint-Antoine - Service de Neurologie Recruiting Paris, France, 75651 Contact: Bruno Stankoff, MD Ph.D 0171970651 bruno.stankoff@aphp.fr 收起 <<
NCT00028730	Leukemia Lymp... 展开 >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms 收起 <<	Phase 2	Completed	-	United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 收起 <<
NCT02257385	Pulmonary Disease, Chronic Obs... 展开 >>tructive 收起 <<	Phase 3	Completed	-	-
NCT02199301	End Stage Renal Disease	Not Applicable	Unknown	December 2017	Korea, Republic of ... 展开 >> Samsung Medical Center, Organ Transplant Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Sung Joo Kim, MD, PhD 82-2-3410-3476 kmhyj.kim@samsung.com Contact: Jae Berm Park, MD, PhD 82-2-3410-3647 jbparkmd@gmail.com Principal Investigator: Sung Joo Kim, MD, PhD Sub-Investigator: Jae Berm Park, MD, PhD 收起 <<
NCT03366168	-		Recruiting	December 31, 2022	United States, Maryland ... 展开 >> National Institute of Aging, Clinical Research Unit Recruiting Baltimore, Maryland, United States, 21224 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) 800-411-1222 ext TTY8664111010 prpl@cc.nih.gov 收起 <<
NCT01297114	-		Completed	-	United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 <<
NCT00787254	Stomach Ulcer ... 展开 >> Duodenal Ulcer 收起 <<	Phase 3	Completed	-	-
NCT03659435	Bioequivalence	Phase 1	Recruiting	November 30, 2018	Germany ... 展开 >> SocraTec R&D GmbH, Clinical Pharmacology Unit Recruiting Erfurt, Thüringen, Germany, 99084 Contact: Cornelius Koch, MD +49-361-60205 ext 67 cornelius.koch@socratec-pharma.de 收起 <<
NCT00787254	-		Completed	-	-
NCT00711958	Anemia	Phase 3	Completed	-	Germany ... 展开 >> Gemeinschaftspraxis Drs. Brudler, Heinrich, Bangerter Augsburg, Germany, 86150 Gemeinschaftspraxis mit Schwerpunkt Hämatologie und Internistische Onkologie Bad Soden, Germany, 65812 Poliklinik am Paritätischen Krankenhaus Berlin, Germany, 10365 Schwerpunktpraxis für Brustkrankheiten und Gynäkologische Onkologie Berlin, Germany, 10367 Oskar-Helene-Heim Berlin, Germany, 14195 Praxis Drs. Marschner, Zeiss, Kirste Freiburg, Germany, 79106 DRK-Krankenhaus Luckenwalde, Germany, 14943 Praxis für Onkologie Munich, Germany, 80637 Praxis Drs. Kowolik/Prechtl Munich, Germany, 81925 Klinikum Nürnberg, 5. Medizinische Klinik Haus 12, Zimmer Nr. 13 Nürnberg, Germany, 90419 Gemeinschaftspraxis Stuttgart, Germany, 70173 Robert-Bosch-Krankenhaus Stuttgart, Germany, 70376 Universitätsklinikum Tübingen Medizinische Klinik 1 Tübingen, Germany, 72076 Gemeinschaftspraxis für internistische Onkologie Velbert, Germany, 42551 Praxis für internistische Onkologie Weiden, Germany, 92637 Romania Oncologic Institute Cluj-Napoca, Romania, 400015 Country hospital Oradea Oradea, Romania, 410032 County Hospital Satu-Mare Satu-Mare, Romania, 440192 Oncomed SRL Timisoara Timisoara, Romania, 300239 收起 <<
NCT03026309	-		Not yet recruiting	March 2019	-
NCT00711958	-		Completed	-	-
NCT02766777	Constipation - Functional	Phase 3	Completed	-	United States, Arkansas ... 展开 >> Northwest Arkansas Pediatric Clinic Fayetteville, Arkansas, United States, 72703 United States, Illinois Methodist Medical Center Peoria, Illinois, United States, 61602 United States, Louisiana Willis-Knighton Physician Network Shreveport, Louisiana, United States, 71101 United States, Nebraska Pioneer Clinical Research Bellevue, Nebraska, United States, 68005 United States, Ohio PriMed Clinical Research Beavercreek, Ohio, United States, 45431 United States, Oregon Cyn3rgy Research Gresham, Oregon, United States, 97030 United States, South Carolina Coastal Clinical Research Charleston, South Carolina, United States, 29414 Coastal Pediatrics Associates - Mount Pleasant Mount Pleasant, South Carolina, United States, 29464 Spartanburg Medical Research Spartanburg, South Carolina, United States, 29303 United States, Texas 3rd Coast Research Associates Corpus Christi, Texas, United States, 78413 United States, Utah Bridgerland Clinical Research Logan, Utah, United States, 84341 Wee Care Pediatrics Syracuse, Utah, United States, 84075 United States, Virginia Pediatric Research of Charlottesville, LLC Charlottesville, Virginia, United States, 22902 收起 <<
NCT00185224	Contraception	Phase 2	Completed	-	Germany ... 展开 >> Bayer Schering Pharma AG - Clin. Pharm. Berlin Berlin, Germany, 13342 收起 <<
NCT02831283	Alzheimer's Disease	Phase 2	Enrolling by invitation	June 2021	United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 <<
NCT03507257	-		Recruiting	August 31, 2023	United States, California ... 展开 >> University of California, San Francisco Recruiting San Francisco, California, United States, 94121 Contact: Julie Pham Julie.pham@ucsf.edu Principal Investigator: Gil Rabinovici, MD United States, Florida Mayo Clinic, Jacksonville Recruiting Jacksonville, Florida, United States, 32224 Contact: Sabrina Bunn 904-953-3930 bunn.sabrina@mayo.edu Principal Investigator: Neill Graff-Radford, MD United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Kristine Lipowski 312-503-2486 k-lipowski@northwestern.edu Principal Investigator: Emily Rogalski, PhD United States, Indiana Indiana University Recruiting Indianapolis, Indiana, United States, 47405 Contact: IU LEADS Team 317-963-7436 iuLEADS@iupui.edu Principal Investigator: Liana Apostolova, MD United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Ryn Flaherty 617-726-1455 rflaherty3@mgh.harvard.edu Principal Investigator: Brad Dickerson, MD United States, Minnesota Mayo Clinic, Rochester Suspended Rochester, Minnesota, United States, 55905 United States, Missouri Washington University, St. Louis Recruiting Saint Louis, Missouri, United States, 63130 Contact: Lisa Cash 314-362-7093 cashl@mir.wustl.edu Principal Investigator: Gregory Day, MD, MSc United States, Pennsylvania University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Grace Stockbower 215-746-3949 grace.stockbower@uphs.upenn.edu Principal Investigator: David Wolk, MD United States, Rhode Island Butler Hospital Recruiting Providence, Rhode Island, United States, 02906 Contact: Sara Hooley 401-455-6403 shooley@butler.org Principal Investigator: Stephen Salloway, MD, MS United States, Texas Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Tierra Ledet tledet@houstonmethodist.org Principal Investigator: Joseph Masdeu, MD, PhD 收起 <<
NCT03283449	Primary Progressive Aphasia Wi... 展开 >>th Suspected Alzheimer's Disease 收起 <<	Phase 1	Recruiting	February 1, 2023	United States, Illinois ... 展开 >> Cognitive Neurology and Alzheimer's Disease Center - Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Christina Coventry, MS, RN 312-908-9681 christina.coventry@northwestern.edu Contact: Emily Rogalski, Ph.D. 312-503-1155 erogalski@gmail.com Principal Investigator: Emily Rogalski, Ph.D. 收起 <<
NCT01028521	Healthy	Phase 1	Completed	-	Germany ... 展开 >> Parexel International GmbH Berlin, Germany, 14050 收起 <<
NCT03093883	Heathy Volunteers	Phase 1	Completed	-	Austria ... 展开 >> Medical University of Vienna Vienna, Austria, 1090 收起 <<
NCT01165502	Healthy	Phase 1	Completed	-	Germany ... 展开 >> Parexel International GmbH Berlin, Germany, 14050 收起 <<
NCT03075007	-		Recruiting	November 2019	United States, New York ... 展开 >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Christiane Hale 646-317-4072 收起 <<
NCT01058941	Alzheimer's Disease	Phase 1 Phase 2	Completed	-	United States, Oregon ... 展开 >> Oregon Health & Science University Portland, Oregon, United States, 97239 收起 <<
NCT01255137	Adrenal Cortex Neoplasms	Phase 2	Completed	-	United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 <<
NCT03074643	Obesity Weigh... 展开 >>t Loss Diet Modification Aging Weight Change, Body Dietary Habits 收起 <<	Not Applicable	Recruiting	September 2020	United States, North Carolina ... 展开 >> Geriatric Research Center at Wake Forest Baptist Health Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Kim Kennedy 336-713-8567 kkennedy@wakehealth.edu 收起 <<
NCT00667979	Erectile Dysfunction	Phase 4	Completed	-	-
NCT01058941	-		Completed	-	-
NCT01255137	-		Completed	-	-
NCT02391181	Healthy Volunteers	Phase 1	Completed	-	Austria ... 展开 >> Medical University of Vienna Vienna, Austria, 1090 收起 <<
NCT02370524	Alzheimer's Disease (AD)	Phase 1	Completed	-	United States, Connecticut ... 展开 >> Molecular NeuroImaging, LLC New Haven, Connecticut, United States, 06510 收起 <<
NCT00762359	Stomach Ulcer ... 展开 >> Duodenal Ulcer 收起 <<	Phase 3	Terminated(AG-1749 superior to... 展开 >> Gefarnate in ulcer prevention) 收起 <<	-	-
NCT03466736	-		Recruiting	April 30, 2022	United States, Utah ... 展开 >> University of Utah Recruiting Salt Lake City, Utah, United States, 84108 Contact: Kevin Duff 801-585-9983 kevin.duff@hsc.utah.edu 收起 <<
NCT03718494	Alzheimer Dementia	Phase 4	Enrolling by invitation	June 2022	United States, Arizona ... 展开 >> Banner Health Phoenix, Arizona, United States, 85032 United States, California University of California San Francisco San Francisco, California, United States, 94158 United States, Connecticut Yale University New Haven, Connecticut, United States, 06520 United States, Massachusetts Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 United States, New York Columbia University New York, New York, United States, 10027 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 收起 <<
NCT01009359	Diagnostic Imaging	Phase 1	Completed	-	Finland ... 展开 >> Turku, Finland, 20520 Netherlands Amsterdam, Netherlands, 1081 HV 收起 <<
NCT03292445	Immune Tolerance	Early Phase 1	Recruiting	February 14, 2024	United States, California ... 展开 >> Stanford University Medical Center Recruiting Palo Alto, California, United States, 94304 Contact: Asha Shori, CCRP 650-736-0245 ashas@stanford.edu Contact: Stephan Busque, MD, MS 650-498-6189 sbusque@stanford.edu Principal Investigator: John D Sandling, MD Sub-Investigator: Judith A Shizuru, MD Sub-Investigator: Marc L Melcher, MD Sub-Investigator: Richard T Hoppe, MD Sub-Investigator: Robert Lowsky, MD Principal Investigator: Samuel Strober, MD Principal Investigator: Stephan Busque, MD 收起 <<
NCT02042183	Constipation - Functional	Phase 3	Completed	-	-
NCT02388165	Staphylococcal Vaccine	Phase 2	Recruiting	August 16, 2019	-
NCT03024944	Diabetes Mellitus ... 展开 >> Alzheimer Dementia 收起 <<	Phase 2	Withdrawn(18F-THK5351 was repo... 展开 >>rted non-specific binding of MAO receptors.) 收起 <<	January 2020	United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 <<
NCT03372317	-		Recruiting	December 2023	United States, New York ... 展开 >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Ann Ann Ohkawa 212-305-6314 ao2454@cumc.columbia.edu Contact: Lamia Hader 212-305-6314 lh2800@cumc.columbia.edu Principal Investigator: Yaakov Stern, PhD 收起 <<
NCT00762359	-		Terminated(AG-1749 superior to... 展开 >> Gefarnate in ulcer prevention) 收起 <<	-	-
NCT03389100	Diabetes Mellitus, Type 2 ... 展开 >> Pre-diabetes 收起 <<	Phase 2	Enrolling by invitation	June 2021	United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 <<
NCT03052296	-		Recruiting	May 2019	Spain ... 展开 >> Hospital Mataró Recruiting Barcelona, Spain Contact: Jesus Alos Principal Investigator: Jesus Alos Hospital Josep Trueta Not yet recruiting Girona, Spain Contact: Omar Andrés Principal Investigator: Omar Andrés Hospital San Cecilio Not yet recruiting Granada, Spain Contact: Jorge Cuenca Manteca Principal Investigator: Jorge Cuenca Manteca Hospital General Universitario Gregorio Maranon Not yet recruiting Madrid, Spain Contact: JOSE MANUEL LIGERO Principal Investigator: JOSE MANUEL LIGERO Hospital Regional Universitario de Málaga Not yet recruiting Málaga, Spain Contact: José Joaquin Munoz Ruiz-Canela Principal Investigator: José Joaquin Munoz Ruiz-Canela Hospital Virgen de la Macarena Not yet recruiting Sevilla, Spain Contact: Raphael Salmeron Principal Investigator: Raphael Salmeron Hospital Clínico Lozano Blesa Zaragoza Recruiting Zaragoza, Spain Contact: Alicia Laborda, MD Contact: Celia Lahuerta, MD Principal Investigator: Miguel Angel de Gregorio 收起 <<
NCT03512171	Healthy Adults	Phase 3	Completed	-	United States, Tennessee ... 展开 >> Zald Affective Neuroscience Lab- Vanderbilt University Nashville, Tennessee, United States, 37203 收起 <<
NCT02138136	Constipation - Functional	Phase 3	Completed	-	-
NCT03706261	Tau and Amyloid Aggregation in... 展开 >> Racially/Ethnically Diverse Adults 收起 <<	Phase 1	Not yet recruiting	June 2023	-
NCT00666835	Anemia	Phase 3	Completed	-	-
NCT00666835	-		Completed	-	-
NCT02884492	Alzheimer's Disease	Phase 2	Terminated(Stopped due to publ... 展开 >>ished data regarding THK-5351 non-specificity in Tau imaging) 收起 <<	-	United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 <<
NCT02884492	-		Terminated(Stopped due to publ... 展开 >>ished data regarding THK-5351 non-specificity in Tau imaging) 收起 <<	-	-
NCT01221610	Atherosclerosis ... 展开 >> Arteriosclerosis Vascular Disease Peripheral Artery Disease 收起 <<	Not Applicable	Completed	-	Austria ... 展开 >> AKH Wien, Kardiovaskuläre und Interventionelle Radiologie Vienna, Austria Germany Universitäts-Herzzentrum Freiburg Bad Krozingen Bad Krozingen, Germany Gefaesszentrum Berlin, Medizinische Klinik, Ev. Krankenhaus Königin Elisabeth Herzberge Berlin, Germany Parkkrankenhaus Leipzig Südost GmbH Leipzig, Germany Institut für diagnostische und interventionelle Radiologie, Klinikum Rosenheim Rosenheim, Germany 收起 <<
NCT01957878	Genital Infection Viral ... 展开 >> HUMAN PAPILLOMA VIRUS 收起 <<	Phase 2	Completed	-	-
NCT03052309	-		Recruiting	February 2020	Belgium ... 展开 >> Ziekenhuis Oost Limburg Genk Recruiting Genk, Belgium Contact: Wouter Lansink Principal Investigator: Wouter LANSINK University Hospital Gent (UZ Gent) Recruiting Gent, Belgium Contact: Frank VERMASSEN Principal Investigator: Frank VERMASSEN Algemeen Ziekenhuis Groeninge Kortrijk Recruiting Kortrijk, Belgium Contact: Annelies Grimonprez Principal Investigator: Philip LERUT Algemeen Ziekenhuis Delta Roeselare Not yet recruiting Roeselare, Belgium Contact: Paul Dujardin Principal Investigator: Paul DUJARDIN AZ Portaels Recruiting Vilvoorde, Belgium Contact: Jorn ROBIJN Principal Investigator: Jorn ROBIJN Luxembourg Centre Hospitaliers Luxembourg Recruiting Luxembourg, Luxembourg Contact: Nicolas Verbeeck Principal Investigator: Nicolas VERBEECK Netherlands OLVG Recruiting Amsterdam, Netherlands Contact: JGAM BLOMJOUS Principal Investigator: JGAM BLOMJOUS Maasstad Ziekenhuis Not yet recruiting Rotterdam, Netherlands Contact: Dammis Vroegindeweij Principal Investigator: Dammis Vroegindeweij Maxima Medisch Centrum Veldhoven Recruiting Veldhoven, Netherlands Contact: J.W.H KRUIMER Principal Investigator: J.W.H KRUIMER 收起 <<
NCT02276313	-		Active, not recruiting	February 2019	-
NCT01867736	Atherosclerosis ... 展开 >> Arteriosclerosis Vascular Disease Peripheral Artery Disease 收起 <<	Not Applicable	Completed	-	Austria ... 展开 >> Medical University of Graz Graz, Austria Belgium Imelda Hospital Bonheiden, Belgium A.Z. Sint-Blasius Dendermonde, Belgium Germany Universitäts-Herzzentrum Freiburg Bad Krozingen, Germany Gefaesszentrum Berlin, Medizinische Klinik, Ev. Krankenhaus Königin Elisabeth Herzberge Berlin, Germany Parkkrankenhaus Leipzig Südost GmbH Leipzig, Germany 收起 <<
NCT02831972	Healthy	Phase 1	Completed	-	United States, Arizona ... 展开 >> Tempe, Arizona, United States, 85283 收起 <<
NCT01202994	-		Active, not recruiting	-	-
NCT03189485	Normal Controls	Early Phase 1	Enrolling by invitation	May 31, 2022	United States, Pennsylvania ... 展开 >> UPenn Philadelphia, Pennsylvania, United States, 19104 收起 <<
NCT03173248	Newly Diagnosed Acute Myeloid ... 展开 >>Leukemia (AML) Untreated AML AML Arising From Myelodysplastic Syndrome (MDS) Leukemia, Myeloid, Acute 收起 <<	Phase 3	Recruiting	June 2022	-
NCT01364571	Staphylococcal Infections	Phase 1 Phase 2	Completed	-	United States, Florida ... 展开 >> Pfizer Investigational Site Pembroke Pines, Florida, United States, 33026 Pfizer Investigational Site South Miami, Florida, United States, 33143 United States, Kansas Pfizer Investigational Site Overland Park, Kansas, United States, 66212 United States, Kentucky Pfizer Investigational Site Bardstown, Kentucky, United States, 40004 United States, Maryland Pfizer Investigational Site Baltimore, Maryland, United States, 21201 United States, Minnesota Pfizer Investigational Site Saint Paul, Minnesota, United States, 55114 United States, New York Pfizer Investigational Site Buffalo, New York, United States, 14202 United States, North Carolina Pfizer Investigational Site Cary, North Carolina, United States, 27518 United States, Ohio Pfizer Investigational Site Cincinnati, Ohio, United States, 45206 Pfizer Investigational Site Cincinnati, Ohio, United States, 45229 United States, Tennessee Pfizer Investigational Site Knoxville, Tennessee, United States, 37920 Pfizer Investigational Site Nashville, Tennessee, United States, 37232 United States, Texas Pfizer Investigational Site Austin, Texas, United States, 78705 Pfizer Investigational Site Houston, Texas, United States, 77081 收起 <<
NCT02364596	Staphylococcal Infections	Phase 1	Completed	-	United States, Florida ... 展开 >> Broward Research Group Hollywood, Florida, United States, 33024 Miami Research Associates South Miami, Florida, United States, 33143 收起 <<
NCT01661231	Peripheral Artery Disease ... 展开 >> Peripheral Vascular Disease 收起 <<	Not Applicable	Active, not recruiting	October 2018	Austria ... 展开 >> Medical University of Graz Graz, Austria Belgium Imelda Ziekenhuis Bonheiden, Belgium AZ St.-Blasius Hospital Dendermonde, Belgium Regionaal Ziekenhuis Heilig Hart Tienen Tienen, Belgium Germany Klinikum Arnsberg, Karolinen Hospital Huesten Arnsberg, Germany Universitätsklinikum Münster Münster, Germany Switzerland University Hospital of Bern Bern, Switzerland 收起 <<
NCT01202994	Alzheimer's Disease	Phase 2	Active, not recruiting	December 2018	United States, Utah ... 展开 >> University of Utah Center for Alzheimer's Care, Imaging and Research Salt Lake City, Utah, United States, 84108 收起 <<
NCT02391935	Intrinsic Aging of Skin ... 展开 >> Skin Wrinkling Solar Degeneration of Skin 收起 <<	Phase 1	Completed	-	Germany ... 展开 >> IUF Leibniz-Institut für umweltmedizinische Forschung gGmbH Düsseldorf, Germany, 40225 收起 <<
NCT03390504	Urothelial Cancer	Phase 3	Recruiting	February 1, 2021	-
NCT01059344	Ulcerative Colitis	Phase 3	Completed	-	Belarus ... 展开 >> Gomel Regional Clinical Hospital, 9 Gomel, Belarus, 23602 City Clinical Hospital No.1 Minsk, Belarus, 220013 Minsk Regional Clinical Hospital, 41 Minsk, Belarus, 2230 City Clinical Hospital No. 2 Minsk, Belarus E.Klumov City Clinical Hospital No. 3 Minsk, Belarus Vitebsk Regional Clinical Hospital Vitebsk, Belarus, 210037 India Medwin Hospital Hyderabad, Andhrapradesh, India, 500 001 Osmania General Hospital Hyderabad, Andhrapradesh, India, 500 012 M.S.Ramiah Hospital Bangalore, Karnataka, India, 560 054 Shree Gokulam Medical College and Research Foundation Trivandrum, Kerala, India, 695 607 S. R. Kalla Memorial Gastro and General Hospital Jaipur, Rajasthan, India, 302 001 Life Line Hospital Chennai, TamilNadu, India, 600 096 Maulana Azad Medical College and Associated Lok Nayak Hospital New Delhi, India, 110 002 Institute of liver and billiary sciences New Delhi, India, 110 070 Turkey Ankara University Medical Faculty Sihhiye Ankara, Turkey, 06100 Hacettepe University Medical Faculty Sihhiye Ankara, Turkey, 06100 Gazi University Medical Faculty Besevler Ankara, Turkey, 06500 Dicle University Medical Faculty Diyarbakir, Turkey, 21280 Trakya University Medical Faculty Edirne, Turkey, 22030 Gaziantep University Medical Faculty Kampus Alani Gaziantep, Turkey, 27310 Sisli Etfal Egitim ve Arastirma Hospital Sisli Istanbul, Turkey, 34360 Dokuz Eylul University Medical Faculty Inciralti Izmir, Turkey, 35340 Ataturk Egitim ve Arastirma Hospital Basin Sitesi Izmir, Turkey, 35360 Ukraine Dnipropetrovska derzhavna medychna akademiia, Dnipropetrovsk, Ukraine, 4904 Ivano-Frankivskyi natsionalnyi medychnyi universytet, Ivano-Frankivsk, Ukraine Miska klinichna likarnia 2, Kharkiv, Ukraine, 61001 Natsionalnyi medychnyi universytet im. Bogomoltsia, kafedra khirurgii 1 na bazi viddilennia proctologii Miskoi klinichnoi likarni 18, m.Kyiv Kyiv, Ukraine, 01030 Natsionalnyi medychnyi universytet im. O.O. Bogomoltsia, Kyiv, Ukraine, 04053 Natsionalna medychna akademia pisliadyplomnoi osvity im. P.L. Shupyk, Kyiv, Ukraine, 04201 Lvivskyi natsionalnyi medychnyi universytet imeni Danyla Galytskogo, Lviv, Ukraine Odeska oblasna klinichna likarnia, Oblasnyi tsentr gastroenterologii, Odessa, Ukraine, 65039 收起 <<
NCT00154310	Renal Transplantation	Phase 4	Completed	-	Germany ... 展开 >> Novartis Investigational Sites Nurnberg, Germany Switzerland Novartis Pharma AG Basel, Switzerland Novartis Investigational Sites Bern, Switzerland 收起 <<
NCT01059344	-		Completed	-	-
NCT02679053	Depression	Not Applicable	Completed	-	Switzerland ... 展开 >> Psychiatric University Hospital Basel, Switzerland, 4012 Psychiatric Services Solothurn Solothurn, Switzerland, 4503 收起 <<
NCT00154310	-		Completed	-	-
NCT01297049	Diabetes Type 2 ... 展开 >> Obesity 收起 <<	Not Applicable	Completed	-	Norway ... 展开 >> Oslo College University Oslo, Arkeshus, Norway, 0130 收起 <<
NCT00405587	Malignant Melanoma ... 展开 >> Colorectal Carcinoma 收起 <<	Phase 1	Completed	-	United States, California ... 展开 >> University of California Los Angeles Los Angeles, California, United States, 90095 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Australia, Victoria Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 3002 Royal Melbourne Hospital Parkville, Victoria, Australia 收起 <<
NCT02699385	Gastroenteritis	Phase 3	Terminated(Study prematurely t... 展开 >>erminated upon recommendation of IDMC due to lack of efficacy.) 收起 <<	-	Austria ... 展开 >> Gröbming, Austria Salzburg, Austria Vienna, Austria Wien N/A, Austria Belgium Brussels, Belgium Brussel, Belgium Herbeumont, Belgium Massemen, Belgium Moorsel, Belgium Russian Federation Novosibirsk, Russian Federation St. Petersburg, Russian Federation St.Petersburg, Russian Federation South Africa Cape Town, South Africa Durban, South Africa Krugersdorp, South Africa Middelburg, South Africa Newtown, South Africa Pietermaritzburg, South Africa Pretoria, South Africa Spain Borriana, Spain Gandia, Spain Valencia, Spain Vic, Spain United Kingdom Barnsley, United Kingdom Ipswich, United Kingdom Maidstone, United Kingdom Middlesborough, United Kingdom Nottingham, United Kingdom Oldham, United Kingdom Staffordshire, United Kingdom Sutton In Ashfield, United Kingdom Tunbridge Wells, United Kingdom 收起 <<
NCT00409799	Tibia Plateau Fractures	Phase 2	Completed	-	-
NCT00183092	Creutzfeldt-Jakob Disease	Phase 2	Completed	-	United States, California ... 展开 >> University of California, San Francisco San Francisco, California, United States, 94143 收起 <<
NCT00183092	-		Completed	-	-
NCT00405587	-		Completed	-	-
NCT01791062	Focal Chondral Defect in Femor... 展开 >>o-tibial Compartment of the Knee Joint 收起 <<	Not Applicable	Completed	-	Germany ... 展开 >> Klinikum Osnabrück GmbH Finkenhügel, Klinik für Orthopädie, Unfall- und Handchirurgie Osnabrück, Niedersachsen, Germany, 49076 收起 <<
NCT00915486	Diabetic Foot Ulcer	Phase 2	Completed	-	Czech Republic ... 展开 >> Diabetologické centrum, I. Interní klinika FN Hradec Králové, Fakultní nemocnice Hradec Králové (21) Hradec Králové, Czech Republic, 500 05 Interní klinika 2. Lékařské fakulty UK a FN Motol, Fakultní nemocnice Motol (22) Praha, Czech Republic, 150 06 Lékařský dum Ormiga Angiologická a diabetologická ambulance (20) Zlín, Czech Republic, 760 01 Oddelení diabetologie - Podiatricka ambulance Krajská zdravotní a.s.- Masarykova nemocnice v Ústí nad Labem o.z. (23) Ústí nad Labem, Czech Republic, 401 13 Germany Klinikum Sindelfingen-Böblingen (01) Böblingen, Germany, 71031 SRH Klinikum Karlsbad-Langensteinbach (04) Karlsbad, Germany, 76307 Klinikum Stuttgart Bürgerhospital (03) Stuttgart, Germany, 70191 Universitätsklinik Tübingen Chirugische Poliklinik (02) Tübingen, Germany, 72076 Hungary Budai Irgalmasrendi Közhasznú Non-Profit Kft (35) Budapest, Hungary, 1027 Fõvárosi Önkormányzat Egyesített Szent István és Szent László Kórház - Rendelõintézet Sebészeti Osztály (32) Budapest, Hungary, 1097 Fővárosi Önkormányzat Szent Imre Kórház Operativ Szakmák Mátrix Szervezete Általános Sebészeti Profil (33) Budapest, Hungary, 1115 Esztergom Város Önkormányzat Vaszary Kolos Kórház Sebészeti Osztály (34) Esztergom, Hungary, 2500 Kaposi Mór Oktató Kórház (38) Kaposvar, Hungary, 7400 Bács-Kiskun Megyei Önkormányzat Kórháza Szegedi Tudományegyetem Általános Orvostudományi Kar Oktató Kórháza, 2. Belgyógyászat (31) Kecskemét, Hungary, 6000 Borsod-Abaúj-Zemplén Megyei Kórház és Egyetemi Oktató Kórház Érsebészeti Osztály (30) Miskolc, Hungary, 3526 PTE Klinikai Központ Érsebészeti Klinikai Tanszék (36) Pécs, Hungary, 7623 SZTE Szent-Györgyi Albert Klinikai Centrum (37) Szeged, Hungary, 6720 Romania Institutul Naţional de Diabet, Nutriţie şi Boli Metabolice "Prof. Dr. N. C. Paulescu" (42) Bucharest, Romania, 020475 Spitalul Clinic Judeţean de Urgenţă Cluj (43) Cluj-Napoca, Romania, 400006 Spitalul Clinic Judeţean Mureş, Clinica de Dermatologie (40) Tg Mures, Romania, 540342 Cabinet Medical Individual DermaMed (41) Tg. Mures,, Romania, 540530 Spitalul Clinic Judetean de Urgenta Timisoara (45) Timisoara, Romania, 300723 Russian Federation Moscow City Clinical Hospital # 13 (11) Moscow, Russian Federation, 115280 Moscow State University of Public Health "City Clinical (17) Moscow, Russian Federation, 115432 Department of Endocrinology and Diabetes, Russian State Medical University, Moscow City Clinical Hospital # 1 (15) Moscow, Russian Federation, 117049 Department of Diabetic Foot Endocrinology dispensary (12) Moscow, Russian Federation, 119034 Endocrinology Clinic of the State Educational Institute of High Professional Education (18) Moscow, Russian Federation, 119992 Federal State Institution "Federal Bureau of Medical Social Expertise" (10) Moscow, Russian Federation, 123448 Moscow Clinical Hospital # 81 (14) Moscow, Russian Federation, 127644 Serbia Klinički centar Srbije, Institut za endokrinologiju, dijabetes i bolesti metabolizma (51) Belgrade, Serbia, 11 000 Clinical Centre Kragujevac (54) Kragujevac, Serbia, 34 000 Clinical Centre Nis (50) Nis, Serbia, 18000 Clinical Centre of Vojvodina (53) Novi Sad, Serbia, 21 000 Health Centre Valjevo (52) Valjevo, Serbia, 14 000 收起 <<
NCT00590707	Hip Fractures ... 展开 >> Delirium 收起 <<	Not Applicable	Completed	-	United States, Maryland ... 展开 >> The Johns Hopkins Bayview Medical Center Baltimore, Maryland, United States, 21224 收起 <<
NCT02854033	-		Recruiting	October 2021	-
NCT00590707	-		Completed	-	-
NCT03431571	Hypermetropia	Not Applicable	Recruiting	July 2019	China ... 展开 >> University Medical Center Shanghai Recruiting Shanghai, China Principal Investigator: Zhou Xingtao Tianjin Eye Hospital, Heping District Recruiting Tianjin, China Principal Investigator: Wang Yan Czechia Gemini Eye Clinic Recruiting Zlín, Czechia Principal Investigator: Pavel Stodulka France University Medical Center CHRU Brest Not yet recruiting Brest, France Contact: Beatrice Cochener Principal Investigator: Beatrice Cochener Germany Medical Center Heliosklinikum Not yet recruiting Erfurt, Germany Contact: Marcus Blum Principal Investigator: Marcus Blum, Prof. University Medical Center Universitätsklinikum Gießen Marburg Recruiting Marburg, Germany Contact: Walter Sekundo +49 6421586 6275 Principal Investigator: Walter Sekundo, Prof. India Medical Center Nethradhama Superspeciality Eye Hospital Recruiting Bangalore, India Contact: Sri Ganesh United Kingdom London Vision Clinic Recruiting London, United Kingdom Principal Investigator: Dan Reinstein 收起 <<
NCT03219879	Depressive Disorder	Not Applicable	Recruiting	June 2020	Germany ... 展开 >> Institut für Klinische Psychologie, Krankenhaus Bad Cannstatt, Klinikum Stuttgart Recruiting Stuttgart, Germany Switzerland Universitätsklinik für Psychiatrie und Psychotherapie, Universität Bern Recruiting Bern, Switzerland Zentrum Psychiatrie und Psychotherapie stationär, Psychiatrische Dienste Aargau AG Recruiting Brugg, Switzerland Zentrum für Psychotherapie, Universität Fribourg Recruiting Fribourg, Switzerland Zentrum für seelische Gesundheit, Privatklinik Meiringen Recruiting Meiringen, Switzerland Psychiatrische und Psychotherapeutische Spezialklinik für Frauen, Klinik Meissenberg AG Recruiting Zug, Switzerland Klinik für Psychiatrie und Psychotherapie, UniversitätsSpital Zürich Recruiting Zürich, Switzerland Praxisstelle Psychotherapie, Universität Zürich Recruiting Zürich, Switzerland 收起 <<
NCT03275311	-		Recruiting	December 2020	France ... 展开 >> Institut de Cancérologie de l'Ouest - Paul Papin Recruiting Angers, France, 49933 Contact: Geneviève PERROCHEAU +33 2 40 67 99 77 genevieve.perrocheau@ico.unicancer.fr Contact: Loïc CAMPION loic.campion@ico.unicancer.fr Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Anne JAFFRE +33 5 56 33 78 48 a.jaffre@bordeaux.unicancer.fr Centre François Baclesse Recruiting Caen, France, 14076 Contact: Anne-Valérie GUIZARD +33 2 31 45 52 45 av.guizard@baclesse.unicancer.fr Centre Jean Perrin Recruiting Clermont-ferrand, France, 63011 Contact: Marie-Ange MOURET-REYNIER +33 4 73 27 81 37 marie-ange.mouret-reynier@clermont.unicancer.fr Centre Georges-François Leclerc Recruiting Dijon, France, 21079 Contact: Patrick ARVEUX +33 3 80 73 75 11 parveux@cgfl.fr Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Malgorzata CUCCHI +33 3 20 29 59 47 m-cucchi@o-lambret.fr Centre Léon Bérard Recruiting Lyon, France, 69373 Contact: Thomas BACHELOT +33 4 78 78 26 54 thomas.bachelot@lyon.unicancer.fr Institut Paoli-Calmettes Recruiting Marseille, France, 13273 Contact: Lilian LABORDE +33 4 91 22 35 10 LABORDEL@ipc.unicancer.fr Institut régional du Cancer Montpellier / Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: Jean-Pierre BLEUSE +33 4 67 61 23 44 jean-pierre.bleuse@icm.unicancer.fr Institut de Cancérologie de Lorraine Recruiting Nancy, France Contact: Carine LAURENT +33 3 83 59 83 32 c.laurent@nancy.unicancer.fr Institut de cancérologie de l'Ouest - René Gauducheau Recruiting Nantes, France, 44805 Contact: Geneviève PERROCHEAU +33 2 40 67 99 77 genevieve.perrocheau@ico.unicancer.fr Contact: Loïc CAMPION loic.campion@ico.unicancer.fr Centre Antoine Lacassagne Recruiting Nice, France, 06189 Contact: Emmanuel CHAMOREY +33 4 92 03 15 29 emmanuel.chamorey@nice.unicancer.fr Institut Curie Recruiting Paris, France, 75005 Contact: Etienne BRAIN etienne.brain@curie.fr Institut Jean Godinot Recruiting Reims, France, 51056 Contact: Damien PARENT +33 3 26 50 42 76 damien.parent@reims.unicancer.fr Centre Eugène Marquis Recruiting Rennes, France, 35042 Contact: Mathias BRETON +33 2 99 25 32 67 m.breton@rennes.unicancer.fr Centre Henri Becquerel Recruiting Rouen, France, 76038 Contact: Agnès LOEB +33 2 32 08 22 80 agnes.loeb@chb.unicancer.fr Institut Curie - Hôpital René Huguenin Recruiting Saint-Cloud, France, 92210 Contact: Etienne BRAIN +33 1 47 11 15 15 etienne.brain@curie.fr Centre Paul Strauss Recruiting Strasbourg, France, 67065 Contact: Michel VELTEN +33 3 88 25 24 53 mvelten@strasbourg.unicancer.fr Institut Claudius Regaud Recruiting Toulouse, France, 31059 Contact: Delphine BERCHERY 05 31 15 50 60 Berchery.Delphine@iuct-oncopole.fr Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Valérie DEJEAN +33 1 42 11 46 49 valerie.dejean@gustaveroussy.fr Contact: Muriel MONS +33 1 42 11 60 11 muriel.mons@gustaveroussy.fr 收起 <<
NCT01959672	Pancreatic Adenocarcinoma ... 展开 >> Resectable Pancreatic Carcinoma Stage I Pancreatic Cancer Stage IA Pancreatic Cancer Stage IB Pancreatic Cancer Stage II Pancreatic Cancer Stage IIA Pancreatic Cancer Stage IIB Pancreatic Cancer Stage III Pancreatic Cancer 收起 <<	Phase 2	Active, not recruiting	December 2019	United States, Nebraska ... 展开 >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 收起 <<
NCT02740218	-		Recruiting	June 30, 2018	-
NCT03655353	HER2-positive Breast Cancer	Not Applicable	Recruiting	December 31, 2022	Sweden ... 展开 >> Section for Clinical Research & Development Unit Recruiting Uppsala, Sweden, 75185 Contact: Tora Sundin tora.sundin@akademiska.se Contact: Lena Franklin lena.franklin@akademiska.se 收起 <<
NCT01657305	Wounds	Phase 3	Completed	-	Austria ... 展开 >> Medical University of Graz Graz, Austria Landesklinik für Dermatologie Salzburg, Austria Medical University Vienna Vienna, Austria Bulgaria University Multiprofile Hospital for Active Treatment-"Dr. Georgi Stranski" EAD Pleven, Bulgaria University Multiprofile Hospital for Active Treatment "Saint George" Plovdiv, Bulgaria Multiprofile Hospital for Active Treatment- Ruse Ruse, Bulgaria University Multiprofile Hospital for Active Treatment and Emergency Medicine "N.I.Pirogov" Sofia, Bulgaria University Multiprofile Hospital for Active Treatment-Varna at MMA-Sofia Varna, Bulgaria Czechia Universtity Hospital Brno Brno, Czechia University Hospital Olomouc Olomouc, Czechia Finland Päijät-Hämeen keskussairaala Lahti, Finland Satakunnan keskussairaala Pori, Finland Germany Trauma Hospital Berlin, Germany University Hospital Düsseldorf, Germany Essen University Hospital Essen, Germany University Hospital Frankfurt, Germany University Medical Center Freiburg, Germany University Medicine Greifswald Greifswald, Germany HELIOS Clinic Krefeld, Germany University Medical Center Mainz, Germany Klinikum rechts der Isar München, Germany Klinikum Offenbach am Main Offenbach, Germany Poland Univesity Hospital Gdansk Gdansk, Poland Samodzelny Publiczny Szpital Kliniczny Nr. 1 Lublin, Poland 收起 <<
NCT01807650	Wounds	Phase 3	Completed	-	France ... 展开 >> CHU de Bordeaux Bordeaux, France Hôpital de la Conception Marseille, France CHU de Nantes Nantes, France Greece KAT General Hospital of Attica Athens, Greece National University, "Andreas Syggros" Skin & Venereal Diseases Hospital Athens, Greece Aristotle University General Hospital Thessaloniki, Greece Latvia Riga East University Hospital, Microsurgery Center Riga, Latvia Riga East University Hospital, State Burn Center Riga, Latvia Spain Hospital de la Santa Creu i Sant Pau Barcelona, Spain Hospital Universitari Vall d'Hebron Barcelona, Spain Hospital Universitario de Getafe Madrid, Spain Hopital Universitari i Politecnic La Fe Valencia, Spain Hospital Universitario Rio Ortega Valladolid, Spain Hospital Miguel Servet Zaragoza, Spain 收起 <<
NCT01657305	-		Completed	-	-
NCT01807650	-		Completed	-	-
NCT00927667	Hemophilia A	Phase 4	Completed	-	Germany ... 展开 >> Heidelberg, Baden-Württemberg, Germany, 69123 Bonn, Nordrhein-Westfalen, Germany, 53105 Münster, Nordrhein-Westfalen, Germany, 48143 Magdeburg, Sachsen-Anhalt, Germany, 39112 Greece Athens, Greece, 115 27 Italy Milano, Italy, 20122 Padova, Italy, 35121 Parma, Italy, 43100 Roma, Italy, 00161 Spain A Coruña, Spain, 15006 Valencia, Spain, 46026 Sweden Malmö, Sweden, 205 02 Stockholm, Sweden, 171 76 United Kingdom Canterbury, Kent, United Kingdom, CT1 3NG London, United Kingdom, NW3 2QG 收起 <<
NCT02125344	Tubular Breast Cancer Stage II... 展开 >> Tubular Breast Cancer Stage III Mucinous Breast Cancer Stage II Breast Cancer Female NOS Invasive Ductal Breast Cancer HER2 Positive Breast Cancer Inflammatory Breast Cancer 收起 <<	Phase 3	Completed	-	Germany ... 展开 >> NTC Heidelberg, Baden-Württemberg, Germany, 69120 收起 <<
NCT01319604	Glaucoma	Not Applicable	Completed	-	Belgium ... 展开 >> University Hospital Leuven Leuven, Belgium, 3000 Denmark University Hospital Glostrup Glostrup, Denmark, 2600 Spain Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital Universitari i Politècnic la Fe Valencia, Spain, 46026 Switzerland Inselspital Bern, Switzerland, 3010 收起 <<
NCT01566721	-		Active, not recruiting	-	-
NCT01078636	-		Completed	-	-
NCT00127790	Insomnia Pain	Not Applicable	Completed	-	United States, New York ... 展开 >> University of Rochester Sleep Research Laboratory Rochester, New York, United States, 14642 收起 <<
NCT00127790	-		Completed	-	-
NCT01657604	Chronic Myeloid Leukemia	Phase 3	Active, not recruiting	December 2022	-
NCT01689389	-		Completed	-	France ... 展开 >> Research Site Argenteuil Cedex, France Research Site Belley, France Research Site Castelmaurou, France Reserach Site Cavaillon, France Research Site Les Mureaux, France Research Site Lille, France Research Site Marseille, France Research Site Montpellier, France Research Site Nimes Cedex, France Research SIte Obernai, France Research Site Paris, France Research Site Rennes, France Research Site Saintes Cedex, France Research Site Sens, France research Site St Dizier, France Research Site St Egreve Cedex, France Research Site Toulouse, France Research Site Tours, France Research Site Ussel Cedex, France 收起 <<
NCT01566721	Breast Neoplasms	Phase 3	Active, not recruiting	March 3, 2020	-
NCT03323411	-		Active, not recruiting	May 31, 2018	-
NCT02435511	Health Behavior	Not Applicable	Active, not recruiting	September 2019	United States, Illinois ... 展开 >> University of Chicago Medicine - Adult Emergency Department and Primary Care Group clinic Chicago, Illinois, United States, 60637 收起 <<
NCT02790645	Diabetes Mellitus, Type 1	Not Applicable	Completed	-	-
NCT02064491	Non-small Cell Lung Cancer	Phase 2	Completed	-	Finland ... 展开 >> Helsinki University Hospital Espoo, Finland Helsinki University Hospital Helsinki, Finland Oulu University Hospital Oulu, Finland Pori Central Hospital Pori, Finland Tampere University Hospital Tampere, Finland Turku University Hopital Turku, Finland Vaasa Central Hospital Vaasa, Finland 收起 <<
NCT02144610	Critical Limb Ischemia	Phase 3	Terminated	-	-
NCT01210495	Hepatocellular Carcinoma	Phase 2	Completed	-	-
NCT01231971	-		Active, not recruiting	October 2018	-
NCT02356016	Sarcopenic Obesity	Phase 2 Phase 3	Completed	-	-
NCT01827462	-		Completed	-	-
NCT00090402	Alzheimer's Disease ... 展开 >> Oxidative Stress Dementia Hyperlipidemia Inflammation 收起 <<	Phase 1 Phase 2	Completed	-	United States, Oregon ... 展开 >> Oregon Health and Science University Portland, Oregon, United States, 97239 收起 <<
NCT00090402	-		Completed	-	-
NCT02708680	Breast Cancer	Phase 1 Phase 2	Active, not recruiting	January 2020	-
NCT02029352	Carcinoma, Basal Cell	Phase 2 Phase 3	Completed	-	Netherlands ... 展开 >> Maastricht University Medical Centre Maastricht, Limburg, Netherlands, 6202 AZ 收起 <<
NCT00476164	Kidney Transplantation ... 展开 >> Graft Rejection Immunosuppression 收起 <<	Phase 4	Completed	-	United Kingdom ... 展开 >> University Hospital Birmingham Birmingham, United Kingdom, B15 2LN East Kent Hospitals University NHS Foundation Trust Canterbury, United Kingdom, CT1 3NG Univeristy Hospital of Wales Cardiff, United Kingdom, CF14 4XW Epsom & St Helier University Hospitals Trust Carshalton, United Kingdom, SM5 1AA Western Infirmary Glasgow, United Kingdom, G11 6NT Hull Royal Infirmary Hull, United Kingdom, HU3 2JZ St Jame's University Hospital Leeds, United Kingdom, LS9 7TF The Royal Free Hospital London, United Kingdom, NW3 2PF King's College London, Guy's Hospital London, United Kingdom, SE 19RT Imperial College London and West London Renal & Transplantation Centre London, United Kingdom, W12 0NN Manchester Royal Infirmary Manchester, United Kingdom, M13 9WL 收起 <<
NCT02824406	-		Unknown	December 2017	Netherlands ... 展开 >> Academic Medical Center Recruiting Amsterdam, Netherlands Principal Investigator: A J Nederveen, dr. ir. 收起 <<
NCT01853332	-		Completed	-	United States, Massachusetts ... 展开 >> Judge Baker Children's Center Boston, Massachusetts, United States, 02120 收起 <<
NCT01827462	Influenza	Phase 4	Completed	-	United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 <<
NCT01210495	-		Completed	-	-
NCT03385668	Pulmonary Fibrosis	Phase 2	Recruiting	February 2021	France ... 展开 >> Cochin Hospital Recruiting Paris, France, 75014 Contact: Jonathan London, MD +33 (0)1 58 41 41 18 jonathan.london@aphp.fr 收起 <<
NCT02308085	Early Breast Cancer	Not Applicable	Recruiting	December 2028	-
NCT01853332	-		Completed	-	-
NCT03088995	-		Completed	-	France ... 展开 >> Yasmine Dudoit Paris, France, 75013 收起 <<
NCT03325270	Iron-deficiency	Not Applicable	Completed	-	Switzerland ... 展开 >> ETH Zurich Zurich, Switzerland, 8092 收起 <<
NCT01933906	Chronic Phase Chronic Myeloid ... 展开 >>Leukemia 收起 <<	Phase 1	Recruiting	December 2019	Austria ... 展开 >> Klinikum Wels-Grieskirchen GmbH, IV. Interne Abteilung Recruiting Wels, Oberösterreich, Austria, 4600 Contact: Sonja Burgstaller, MD sonja.burgstaller@klinikum-wegr.at Principal Investigator: Sonja Burgstaller, MD Universitätskliniken Innsbruck, Univ.-Klinik f.Innere Medizin V Hämtologie u. Onkologie Recruiting Innsbruck, Austria, A-6020 Contact: Michael Steurer, Prof. MD +43 512 504 ext 81386 michael.steurer@i-med.ac.at Contact: Elke Adamski-kondert@uki.at, Mag. +43512504 ext 80308 elke.adamski-kondert@uki.at Principal Investigator: Micheal Steurer, Prof.MD Ordensklinikum Linz - Elisabethinen Recruiting Linz, Austria, A-4020 Contact: Veronika Buxhofer-Ausch, MD +43 732 7676 ext 4409 veronika.buxhofer-ausch@ordensklinikum.at Contact: Sarah Panholzer, Mag. +43 732 7676 ext 4425 sarah.panholzer@elisabethinen.or.at Principal Investigator: Veronika Buxhofer-Ausch, MD Universitätsklinikum der PMU Salzburg, Universitätsklinik für Innere Medizin III Recruiting Salzburg, Austria, 5020 Contact: Richard Greil, MD r.greil@salk.at Contact: Stefanie Schumy, MA.rer.nat. +43 57255 ext 25821 s.schumy@salk.at Principal Investigator: Richard Greil, MD Med. Univ. Wien, Univ.Klinik f. Innere Medizin I, Hematologie/Hemostaseologie Not yet recruiting Vienna, Austria, A-1090 Contact: Wolfgang Füreder, MD, Prof. +43 1 40400 ext 44690 wolfgang.fuereder@meduniwien.ac.at Contact: Susanne Herndlhofer +43 1 40400 ext 45220 susanne.herndlhofer@meduniwien.ac.at Principal Investigator: Wolfgang Füreder, MD, Prof. Hanusch-Krankenhaus, 3. Medizinische Abteilung Not yet recruiting Vienna, Austria, A-1140 Contact: Thamer Sliwa, MD +43191021 ext 57301 thamer.sliwa@wgkk.at Contact: Kathrin Holzer, Mag. +43191021 ext 85435 kathrin.holzer@wgkk.at Principal Investigator: Thamer Sliwa, MD 收起 <<
NCT02758730	Parkinson's Disease	Phase 1	Withdrawn	-	Germany ... 展开 >> University Hospital Tübingen Tübingen, Germany, 72076 收起 <<
NCT02537808	-		Active, not recruiting	September 2023	Germany ... 展开 >> Hämatologisch-Onkologische Schwerpunktpraxis Bochum, Germany, 44787 收起 <<
NCT03655769	Transcranial Direct Current St... 展开 >>imulation 收起 <<	Not Applicable	Active, not recruiting	December 31, 2018	-
NCT02113215	-		Terminated(PI left UTMB)	-	United States, Texas ... 展开 >> University of Texas Medical Branch, Dept of Surgery Galveston, Texas, United States, 77550 收起 <<
NCT00106899	-		Completed	-	-
NCT03343483	Loneliness Qu... 展开 >>ality of Life 收起 <<	Not Applicable	Recruiting	November 30, 2021	United States, New York ... 展开 >> University of Rochester Recruiting Rochester, New York, United States, 14642 Contact: Kimberly Van Orden, PhD 585-275-5176 kimberly_vanorden@urmc.rochester.edu Principal Investigator: Kimberly A Van Orden, PhD 收起 <<
NCT02488863	-		Recruiting	March 2020	United States, Florida ... 展开 >> UF Health Science Center Recruiting Gainesville, Florida, United States, 32608 Principal Investigator: Yenisel Cruz-Almeida, MSPH, PhD Clinical Translational Research Building Recruiting Gainesville, Florida, United States, 32611 Contact: Yenisel Cruz-Almeida, MSPH, PhD 352-294-8339 收起 <<
NCT01355133	Stress Urinary Incontinence	Phase 1 Phase 2	Completed	-	Slovenia ... 展开 >> University Medical Center Ljubljana, Dept. of Gynecology Ljubljana, Slovenia, 1000 收起 <<
NCT00161473	Alzheimer Disease ... 展开 >> Psychomotor Agitation 收起 <<	Not Applicable	Completed	-	United States, Washington ... 展开 >> Veterans Affairs Puget Sound Health Care System Seattle, Washington, United States, 98108 收起 <<
NCT02830321	-		Completed	-	-
NCT01188226	Dentures	Not Applicable	Terminated(Enrollment difficul... 展开 >>ties and drop outs) 收起 <<	-	United States, California ... 展开 >> UCLA School of Dentistry Los Angeles, California, United States, 90095 收起 <<
NCT01188226	-		Terminated(Enrollment difficul... 展开 >>ties and drop outs) 收起 <<	-	-
NCT00161473	-		Completed	-	-
NCT02011178	Diabetic Kidney Disease	Not Applicable	Withdrawn(No subjects have bee... 展开 >>n enrolled) 收起 <<	December 2017	Sweden ... 展开 >> Ersta hospital Stockholm, Sweden, 116 28 Switzerland St:Claraspital Basel, Switzerland, 4058 收起 <<
NCT02821793	-		Recruiting	July 2020	France ... 展开 >> Institut Bergonié Recruiting Bordeaux, France, 33076 Principal Investigator: SOUBEYRAN Pierre-Louis, MD,PhD 收起 <<
NCT03046381	Schnitzler's Syndrome	Phase 2	Recruiting	July 31, 2019	Germany ... 展开 >> Charité - Universitätsmedizin Berlin, Dpt. of Dermatology and Allergy Recruiting Berlin, Germay, Germany, 10117 Contact: Karoline Krause, MD +49 30 450 518 ext 336 karoline.krause@charite.de Contact: Hanna Bonnekoh, MD +49 30 450 618 ext 077 hanna.bonnekoh@charite.de 收起 <<
NCT00376129	Atopic Dermatitis	Phase 2	Completed	-	Switzerland ... 展开 >> Inselspital Dermatology Bern, Switzerland, 3110 收起 <<
NCT01329952	-		Unknown	June 2014	United Kingdom ... 展开 >> North Manchester General Hospital Manchester, Greater Manchester, United Kingdom, M8 5RB 收起 <<
NCT00495547	Myelodysplastic Syndrome	Phase 2	Terminated	-	Spain ... 展开 >> Hospital Germans Trias i Pujol Badalona, Spain Hospital Clínic Universitari Barcelona, Spain Hospital del Mar Barcelona, Spain Hospital Reina Sofía Córdoba, Spain Hospital Virgen Blanca Leon, Spain Hospital la Paz Madrid, Spain Hospital Central de Asturias Oviedo, Spain Hospital Son Llatzer Palma de mallorca, Spain Hospital Clinico Universitario Salamanca, Spain Hospital La Fe de Valencia Valencia, Spain 收起 <<
NCT02628548	Aging	Not Applicable	Recruiting	December 2021	United States, Massachusetts ... 展开 >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02129 Contact: Sara Lazar, PhD 617-643-6628 lazar@nmr.mgh.harvard.edu 收起 <<
NCT01055132	Astigmatism	Not Applicable	Completed	-	United States, California ... 展开 >> Los Angeles, California, United States, 90049 United States, Florida Jacksonville, Florida, United States, 32205 Jacksonville, Florida, United States, 32256 United States, Georgia Marietta, Georgia, United States, 30060 United States, New York New York, New York, United States, 10001 United States, Rhode Island Warwick, Rhode Island, United States, 02886 收起 <<
NCT01055132	-		Completed	-	-
NCT03356886	Low Back Pain	Not Applicable	Recruiting	December 2018	Brazil ... 展开 >> University of Sao Paulo Recruiting Ribeirão Preto, São Paulo, Brazil, 14049-900 Contact: Thais C Chaves, PhD 55 016 3315 4413 chavestc@fmrp.usp.br Contact: Fernando AG Tavares, Doctor 55 17 98122.9897 osteopatia@allivium.com 收起 <<
NCT00144976	Head and Neck Neoplasms	Not Applicable	Completed	-	France ... 展开 >> Center Oscar Lambret Lille, France Institut claudius regaud Toulouse, France 收起 <<
NCT02221622	Mild Cognitive Impairment ... 展开 >> Alzheimer Disease 收起 <<	Phase 1	Completed	-	United States, California ... 展开 >> University of Southern California - Alzheimer Disease Research Center - Healthcare Consultation Center II Los Angeles, California, United States, 90033 收起 <<
NCT01426880	Tubular Breast Cancer Stage II... 展开 >> Mucinous Breast Cancer Stage II Breast Cancer Female NOS Invasive Ductal Breast Cancer Tubular Breast Cancer Stage III HER-2 Positive Breast Cancer Inflammatory Breast Cancer Stage IV Inflammatory Breast Cancer 收起 <<	Phase 2 Phase 3	Completed	-	Germany ... 展开 >> Praxis Dr. Heinrich Fürstenwalde, Brandenburg, Germany, 15517 Luisenkrankenhaus Düsseldorf, Nordrhein-Westfalen, Germany, 40235 NCT Heidelberg Heidelberg, Germany 收起 <<
NCT02310503	-		Recruiting	July 2019	Spain ... 展开 >> Hospital Universitario de Cruces Recruiting Barakaldo, Spain Contact: Irati Allende Markixana, MD Hospital del Mar Recruiting Barcelona, Spain Contact: Agustí Toll-Abelló, MD Hospital Quirón Teknon Recruiting Barcelona, Spain Contact: Joan Ramón Garcés, MD Sub-Investigator: Elena Manubens.Mercadé, MD Hospital Santa Creu i Sant Pau Recruiting Barcelona, Spain Contact: Joan Ramon Garcés, MD Sub-Investigator: Verónica Ruiz-Salas, MD Complejo Hospitalario Universitario de Guadalajara Recruiting Guadalajara, Spain Contact: Esther De Eusebio Murillo, MD Complejo Asistencial Universitario de León Recruiting León, Spain Contact: Teresa Alonso, MD Sub-Investigator: Manuel Ángel Rodriguez-Prieto, MD Clínica Quirón Recruiting Madrid, Spain Contact: Yolanda Delgado Jiménez, MD Sub-Investigator: Victoriano Morales-Gordillo, MD Hospital de la Princesa Recruiting Madrid, Spain Contact: Yolanda Delgado Jiménez, MD Sub-Investigator: Erich Vargas Diez, MD Hospital Gregorio Marañon Recruiting Madrid, Spain Contact: Lucia Barchino Ortiz, MD Sub-Investigator: Ricardo Suarez, MD Sub-Investigator: Natividad Cano, MD Hospital La Zarzuela Recruiting Madrid, Spain Contact: Cristina Ciudad Blanco, MD Sub-Investigator: Lucia Barchino Ortiz, MD Hospital Universitario Fundación de Alcorcón Recruiting Madrid, Spain Contact: Román Miñano, MD Sub-Investigator: Jose Luis López-Estebaranz, MD Sub-Investigator: Lucia Asacanio Armada, MD Sub-Investigator: Dolores Caro Gutierrez, MD Clínica Universitaria de Navarra Recruiting Pamplona, Spain Contact: Pedro Redondo, MD predondo@unav.es Sub-Investigator: Pilar Gil, MD Complexo Hospitalario Universitario de Santiago Recruiting Santiago de Compostela, Spain Contact: Hugo Vázquez-Veiga, MD Sub-Investigator: María José Seoane Pose, MD Hospital Manises Recruiting Valencia, Spain Contact: Alberto Alfaro Rubio, MD Sub-Investigator: Luis Hueso Gabriel, MD Sub-Investigator: Antonio Martorell, MD Instituto Valenciano de Oncología Recruiting Valencia, Spain Contact: Onofre Sanmartín-Jiménez, MD Sub-Investigator: Carlos Guillén-Barona, MD Sub-Investigator: Carlos Serra Guillen, MD Sub-Investigator: Eduardo Nagore Enguidanos, MD Sub-Investigator: Beatriz Llombart Cussac, MD Sub-Investigator: Celia Requena Caballero, MD 收起 <<
NCT03454334	Cataract	Not Applicable	Enrolling by invitation	December 14, 2018	-
NCT02145949	Muscle Atrophy ... 展开 >> Quality of Life 收起 <<	Phase 2	Suspended	February 2020	United States, Oregon ... 展开 >> University of Oregon Eugene, Oregon, United States, 97401-1240 Slocum Center for Orthopedics and Sports Medicine Eugene, Oregon, United States, 97401 收起 <<
NCT03720379	Dental Caries ... 展开 >> Fluor 收起 <<	Not Applicable	Enrolling by invitation	May 2020	Poland ... 展开 >> Dorota Olczak-Kowalczyk Warsaw, Warsaw, 18 Miodowa Saint, Poland, 00-246 收起 <<
NCT00552604	Muscle Spasticity	Phase 3	Terminated(due to recruitment ... 展开 >>problems / based on recommendation of Independent Review Board) 收起 <<	-	United Kingdom ... 展开 >> Peninsula Medical School Plymouth, United Kingdom, PL6 8BX 收起 <<
NCT03713866	Ventricular Tachycardia ... 展开 >> Myocardial Infarction 收起 <<	Not Applicable	Not yet recruiting	March 1, 2021	-
NCT01565200	HER-2 Positive Breast Cancer	Phase 2	Active, not recruiting	December 2019	Belgium ... 展开 >> Universitair Ziekenhuis Antwerpen (UZA) Antwerpen, Edegem, Belgium, 2650 Institut Jules Bordet Brussels, Belgium, 1000 Netherlands Vrije Universiteit Amsterdam (VUMC) Amsterdam, Netherlands, 1081HV University Medical Center Groningen (UMCG) Groningen, Netherlands, 9700RB Radboud University Medical Centre Nijmegen (UMCN) Nijmegen, Netherlands, 6525 GA 收起 <<
NCT01045902	Pneumonia, Aspiration ... 展开 >> Lung Abscess 收起 <<	Phase 3	Completed	-	Germany ... 展开 >> Mannheim, Baden-Württemberg, Germany, 68167 Nürnberg, Bayern, Germany, 90419 Regensburg, Bayern, Germany, 93053 Treuenbrietzen, Brandenburg, Germany, 14929 Frankfurt, Hessen, Germany, 60596 Hildesheim, Niedersachsen, Germany, 31134 Rotenburg, Niedersachsen, Germany, 27356 Lüdenscheid, Nordrhein-Westfalen, Germany, 58515 Oberhausen, Nordrhein-Westfalen, Germany, 46045 Paderborn, Nordrhein-Westfalen, Germany, 33098 Magdeburg, Sachsen-Anhalt, Germany, 39112 Leipzig, Sachsen, Germany, 04129 Lübeck, Schleswig-Holstein, Germany, 23538 Berlin, Germany, 13353 Berlin, Germany, 14165 收起 <<
NCT00603720	-		Completed	-	-
NCT00603720	Cardiovascular Diseases	Not Applicable	Completed	-	United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 收起 <<
NCT01457144	Mantle Cell Lymphoma	Phase 2	Completed	-	France ... 展开 >> Valerie ROLLAND NEYRET Grenoble, France, 38043 收起 <<
NCT03674086	-		Recruiting	April 30, 2019	United Kingdom ... 展开 >> National Institute for Health Research Nottingham Biomedical Research Centre Recruiting Nottingham, Non-US/Non-Canadian, United Kingdom, NG1 5DU Contact: Melanie A Ferguson, PhD melanie.ferguson@nottingham.ac.uk Principal Investigator: Melanie A Ferguson, PhD 收起 <<

酪氨酸磷酸化抑制剂A23 /AG 18 {[allProObj[0].p_purity_real_show]}

AG 18 纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

AG 18 质控信息

AG 18 生物活性

AG 18 临床研究

AG 18 参考文献

AG 18 实验方案

AG 18 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

酪氨酸磷酸化抑制剂A23 /AG 18 {[allProObj[0].p_purity_real_show]}

AG 18 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

AG 18 质控信息

AG 18 生物活性

AG 18 临床研究

AG 18 参考文献

AG 18 实验方案

AG 18 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

AG 18 纯度/质量文件产品仅供科研